{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T01:30:18Z","timestamp":1794360618149,"version":"4.9.0"},"reference-count":272,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T00:00:00Z","timestamp":1617753600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T00:00:00Z","timestamp":1617753600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["2018\/30\/E\/NZ5\/00065"],"award-info":[{"award-number":["2018\/30\/E\/NZ5\/00065"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Duchenne muscular dystrophy (DMD) is a devastating chromosome X-linked disease that manifests predominantly in progressive skeletal muscle wasting and dysfunctions in the heart and diaphragm. Approximately 1\/5000 boys and 1\/50,000,000 girls suffer from DMD, and to date, the disease is incurable and leads to premature death. This phenotypic severity is due to mutations in the<jats:italic>DMD<\/jats:italic>gene, which result in the absence of functional dystrophin protein. Initially, dystrophin was thought to be a force transducer; however, it is now considered an essential component of the dystrophin-associated protein complex (DAPC), viewed as a multicomponent mechanical scaffold and a signal transduction hub. Modulating signal pathway activation or gene expression through epigenetic modifications has emerged at the forefront of therapeutic approaches as either an adjunct or stand-alone strategy. In this review, we propose a broader perspective by considering DMD to be a disease that affects myofibers and muscle stem (satellite) cells, as well as a disorder in which abrogated communication between different cell types occurs. We believe that by taking this systemic view, we can achieve safe and holistic treatments that can restore correct signal transmission and gene expression in diseased DMD tissues.<\/jats:p>","DOI":"10.1007\/s00018-021-03821-x","type":"journal-article","created":{"date-parts":[[2021,4,7]],"date-time":"2021-04-07T13:05:54Z","timestamp":1617800754000},"page":"4867-4891","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Therapeutic aspects of cell signaling and communication in Duchenne muscular dystrophy"],"prefix":"10.1007","volume":"78","author":[{"given":"Alicja","family":"Starosta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9609-8254","authenticated-orcid":false,"given":"Patryk","family":"Konieczny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,7]]},"reference":[{"key":"3821_CR1","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s13023-020-01430-8","volume":"15","author":"S Crisafulli","year":"2020","unstructured":"Crisafulli S, Sultana J, Fontana A et al (2020) Global epidemiology of Duchenne muscular dystrophy: an updated systematic review and meta-analysis. Orphanet J Rare Dis 15:141. https:\/\/doi.org\/10.1186\/s13023-020-01430-8","journal-title":"Orphanet J Rare Dis"},{"key":"3821_CR2","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.slsci.2016.07.004","volume":"9","author":"KT Nozoe","year":"2016","unstructured":"Nozoe KT, Akamine RT, Mazzotti DR et al (2016) Phenotypic contrasts of Duchenne muscular dystrophy in women: two case reports. Sleep Sci 9:129\u2013133. https:\/\/doi.org\/10.1016\/j.slsci.2016.07.004","journal-title":"Sleep Sci"},{"key":"3821_CR3","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.nmd.2018.04.005","volume":"28","author":"M Ishizaki","year":"2018","unstructured":"Ishizaki M, Kobayashi M, Adachi K et al (2018) Female dystrophinopathy: review of current literature. Neuromuscul Disord 28:572\u2013581. https:\/\/doi.org\/10.1016\/j.nmd.2018.04.005","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"3821_CR4","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S1474-4422(18)30024-3","volume":"17","author":"DJ Birnkrant","year":"2018","unstructured":"Birnkrant DJ, Bushby K, Bann CM et al (2018) Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management. Lancet Neurol 17(3):251\u2013267. https:\/\/doi.org\/10.1016\/S1474-4422(18)30024-3","journal-title":"Lancet Neurol"},{"key":"3821_CR5","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1007\/s12035-019-01845-w","volume":"57","author":"M Naidoo","year":"2020","unstructured":"Naidoo M, Anthony K (2020) Dystrophin Dp71 and the Neuropathophysiology of Duchenne muscular dystrophy. Mol Neurobiol 57:1748\u20131767. https:\/\/doi.org\/10.1007\/s12035-019-01845-w","journal-title":"Mol Neurobiol"},{"key":"3821_CR6","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1152\/jn.00248.2016","volume":"116","author":"MG Rae","year":"2016","unstructured":"Rae MG, O\u2019Malley D (2016) Cognitive dysfunction in Duchenne muscular dystrophy: a possible role for neuromodulatory immune molecules. J Neurophysiol 116:1304\u20131315. https:\/\/doi.org\/10.1152\/jn.00248.2016","journal-title":"J Neurophysiol"},{"key":"3821_CR7","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/S1474-4422(09)70271-6","volume":"9","author":"K Bushby","year":"2010","unstructured":"Bushby K, Finkel R, Birnkrant DJ et al (2010) Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol 9:77\u201393. https:\/\/doi.org\/10.1016\/S1474-4422(09)70271-6","journal-title":"Lancet Neurol"},{"key":"3821_CR8","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3389\/fgene.2011.00064","volume":"2","author":"AK Marrone","year":"2011","unstructured":"Marrone AK, Shcherbata HR (2011) Dystrophin orchestrates the epigenetic profile of muscle cells via miRNAs. Front Genet 2:64. https:\/\/doi.org\/10.3389\/fgene.2011.00064","journal-title":"Front Genet"},{"issue":"5","key":"3821_CR9","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.stem.2018.03.022","volume":"22","author":"NC Chang","year":"2018","unstructured":"Chang NC, Sincennes MC, Chevalier FP, Brun CE, Lacaria M, Segal\u00e9s J, Mu\u00f1oz-C\u00e1noves P, Ming H, Rudnicki MA (2018) The Dystrophin glycoprotein complex regulates the epigenetic activation of muscle stem cell commitment. Cell Stem Cell 22(5):755-768.e6. https:\/\/doi.org\/10.1016\/j.stem.2018.03.022","journal-title":"Cell Stem Cell"},{"key":"3821_CR10","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.cmet.2010.07.008","volume":"12","author":"D Cacchiarelli","year":"2010","unstructured":"Cacchiarelli D, Martone J, Girardi E et al (2010) MicroRNAs involved in molecular circuitries relevant for the duchenne muscular dystrophy pathogenesis are controlled by the dystrophin\/nNOS pathway. Cell Metab 12:341\u2013351. https:\/\/doi.org\/10.1016\/j.cmet.2010.07.008","journal-title":"Cell Metab"},{"issue":"1","key":"3821_CR11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13148-021-01001-z","volume":"13","author":"A Rugowska","year":"2021","unstructured":"Rugowska A, Starosta A, Konieczny P (2021) Epigenetic modifications in muscle regeneration and progression of Duchenne muscular dystrophy. Clin Epigenetics 13(1):13. https:\/\/doi.org\/10.1186\/s13148-021-01001-z","journal-title":"Clin Epigenetics"},{"key":"3821_CR12","doi-asserted-by":"publisher","first-page":"547","DOI":"10.2217\/epi.14.36","volume":"6","author":"S Consalvi","year":"2014","unstructured":"Consalvi S, Saccone V, Mozzetta C (2014) Histone deacetylase inhibitors\u202f: a potential epigenetic treatment for Duchenne muscular dystrophy. Epigenomics 6:547\u2013560. https:\/\/doi.org\/10.2217\/epi.14.36","journal-title":"Epigenomics"},{"key":"3821_CR13","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.nmd.2016.07.002","volume":"26","author":"P Bettica","year":"2016","unstructured":"Bettica P, Petrini S, D\u2019Oria V et al (2016) Histological effects of givinostat in boys with Duchenne muscular dystrophy. Neuromuscul Disord 26:643\u2013649. https:\/\/doi.org\/10.1016\/j.nmd.2016.07.002","journal-title":"Neuromuscul Disord"},{"key":"3821_CR14","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1152\/physrev.00028.2001","volume":"82","author":"DJ Blake","year":"2002","unstructured":"Blake DJ, Weir A, Newey SE, Davies KE (2002) Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiol Rev 82:291\u2013329. https:\/\/doi.org\/10.1152\/physrev.00028.2001","journal-title":"Physiol Rev"},{"key":"3821_CR15","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/S1474-4422(03)00585-4","volume":"2","author":"F Muntoni","year":"2003","unstructured":"Muntoni F, Torelli S, Ferlini A (2003) Dystrophin and mutations: one gene, several proteins, multiple phenotypes. Lancet Neurol 2:731\u2013740. https:\/\/doi.org\/10.1016\/S1474-4422(03)00585-4","journal-title":"Lancet Neurol"},{"key":"3821_CR16","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1093\/hmg\/4.5.837","volume":"4","author":"VN D\u2019souza","year":"1995","unstructured":"D\u2019souza VN, Man NT, Morris GE et al (1995) A novel dystrophin isoform is required for normal retinal electrophysiology. Hum Mol Genet 4:837\u2013842. https:\/\/doi.org\/10.1093\/hmg\/4.5.837","journal-title":"Hum Mol Genet"},{"key":"3821_CR17","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3390\/genes8100251","volume":"8","author":"M Matsuo","year":"2017","unstructured":"Matsuo M, Awano H, Matsumoto M et al (2017) Dystrophin dp116: a yet to be investigated product of the duchenne muscular dystrophy gene. Genes (Basel) 8:251. https:\/\/doi.org\/10.3390\/genes8100251","journal-title":"Genes (Basel)"},{"key":"3821_CR18","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1212\/WNL.55.4.559","volume":"55","author":"G Felisari","year":"2000","unstructured":"Felisari G, Boneschi FM, Bardoni A et al (2000) Loss of Dp140 dystrophin isoform and intellectual impairment in Duchenne dystrophy. Neurology 55:559\u2013564. https:\/\/doi.org\/10.1212\/WNL.55.4.559","journal-title":"Neurology"},{"key":"3821_CR19","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s12035-012-8233-5","volume":"45","author":"T Tozawa","year":"2012","unstructured":"Tozawa T, Itoh K, Yaoi T et al (2012) The shortest isoform of dystrophin (Dp40) interacts with a group of presynaptic proteins to form a presumptive novel complex in the mouse brain. Mol Neurobiol 45:287\u2013297. https:\/\/doi.org\/10.1007\/s12035-012-8233-5","journal-title":"Mol Neurobiol"},{"key":"3821_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-12981-5","volume":"7","author":"N Doorenweerd","year":"2017","unstructured":"Doorenweerd N, Mahfouz A, Van Putten M et al (2017) Timing and localization of human dystrophin isoform expression provide insights into the cognitive phenotype of Duchenne muscular dystrophy. Sci Rep 7:1\u201312. https:\/\/doi.org\/10.1038\/s41598-017-12981-5","journal-title":"Sci Rep"},{"key":"3821_CR21","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.3390\/ijms19061546","volume":"19","author":"T Kawaguchi","year":"2018","unstructured":"Kawaguchi T, Niba ETE, Rani AQM et al (2018) Detection of dystrophin Dp71 in human skeletal muscle using an automated capillary western assay system. Int J Mol Sci 19:1546. https:\/\/doi.org\/10.3390\/ijms19061546","journal-title":"Int J Mol Sci"},{"key":"3821_CR22","first-page":"187","volume":"49","author":"D Rapaport","year":"1992","unstructured":"Rapaport D, Lederfein D, den Dunnen JT et al (1992) Characterization and cell type distribution of a novel, major transcript of the Duchenne Muscular Dystrophy gene. Symp Soc Exp Biol 49:187\u2013193","journal-title":"Symp Soc Exp Biol"},{"key":"3821_CR23","doi-asserted-by":"publisher","first-page":"e0135189","DOI":"10.1371\/journal.pone.0135189","volume":"10","author":"J Juan-Mateu","year":"2015","unstructured":"Juan-Mateu J, Gonzalez-Quereda L, Rodriguez MJ et al (2015) DMD mutations in 576 dystrophinopathy families: a step forward in genotype-phenotype correlations. PLoS ONE 10:e0135189. https:\/\/doi.org\/10.1371\/journal.pone.0135189","journal-title":"PLoS ONE"},{"key":"3821_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pediatrneurol.2006.09.016","volume":"36","author":"N Deconinck","year":"2007","unstructured":"Deconinck N, Dan B (2007) Pathophysiology of Duchenne muscular dystrophy: current hypotheses. Pediatr Neurol 36:1\u20137. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2006.09.016","journal-title":"Pediatr Neurol"},{"key":"3821_CR25","doi-asserted-by":"publisher","first-page":"5142","DOI":"10.1002\/jcp.25982","volume":"233","author":"HF Bhat","year":"2018","unstructured":"Bhat HF, Mir SS, Dar KB et al (2018) ABC of multifaceted dystrophin glycoprotein complex (DGC). J Cell Physiol 233:5142\u20135159. https:\/\/doi.org\/10.1002\/jcp.25982","journal-title":"J Cell Physiol"},{"key":"3821_CR26","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/nyas.13500","volume":"1412","author":"M Gawor","year":"2018","unstructured":"Gawor M, Pr\u00f3szy\u0144ski TJ (2018) The molecular cross talk of the dystrophin\u2013glycoprotein complex. Ann NY Acad Sci 1412:62\u201372. https:\/\/doi.org\/10.1111\/nyas.13500","journal-title":"Ann NY Acad Sci"},{"key":"3821_CR27","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3390\/brainsci5030275","volume":"5","author":"B Nichols","year":"2015","unstructured":"Nichols B, Takeda S, Yokota T (2015) Nonmechanical roles of dystrophin and associated proteins in exercise, neuromuscular junctions, and brains. Brain Sci 5:275\u2013298. https:\/\/doi.org\/10.3390\/brainsci5030275","journal-title":"Brain Sci"},{"key":"3821_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12035-009-8089-5","volume":"41","author":"GSK Pilgram","year":"2010","unstructured":"Pilgram GSK, Potikanond S, Baines RA et al (2010) The roles of the dystrophin-associated glycoprotein complex at the synapse. Mol Neurobiol 41:1\u201321. https:\/\/doi.org\/10.1007\/s12035-009-8089-5","journal-title":"Mol Neurobiol"},{"issue":"17","key":"3821_CR29","doi-asserted-by":"publisher","first-page":"3647","DOI":"10.1093\/hmg\/ddw210","volume":"25","author":"J Zhao","year":"2016","unstructured":"Zhao J, Kodippili K, Yue Y et al (2016) Dystrophin contains multiple independent membrane-binding domains. Hum Mol Genet 25(17):3647\u20133653. https:\/\/doi.org\/10.1093\/hmg\/ddw210","journal-title":"Hum Mol Genet"},{"key":"3821_CR30","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.2741\/3303","volume":"14","author":"RF Feissner","year":"2009","unstructured":"Feissner RF, Skalska J, Gaum WE, Sheu SS (2009) Crosstalk signaling between mitochondrial Ca2+ and ROS. Front Biosci (Landmark Ed) 14:1197\u20131218. https:\/\/doi.org\/10.2741\/3303","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"1","key":"3821_CR31","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13395-018-0177-7","volume":"8","author":"EM Houang","year":"2018","unstructured":"Houang EM, Sham YY, Bates FS, Metzger JM (2018) Muscle membrane integrity in Duchenne muscular dystrophy: recent advances in copolymer-based muscle membrane stabilizers. Skelet Muscle 8(1):31. https:\/\/doi.org\/10.1186\/s13395-018-0177-7","journal-title":"Skelet Muscle"},{"issue":"7","key":"3821_CR32","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1111\/j.1440-1681.2006.04394.x","volume":"33","author":"NP Whitehead","year":"2006","unstructured":"Whitehead NP, Yeung EW, Allen DG (2006) Muscle damage in mdx (dystrophic) mice: role of calcium and reactive oxygen species. Clin Exp Pharmacol Physiol 33(7):657\u2013662. https:\/\/doi.org\/10.1111\/j.1440-1681.2006.04394.x","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"3","key":"3821_CR33","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1002\/jcsm.12405","volume":"10","author":"MC Hughes","year":"2019","unstructured":"Hughes MC, Ramos SV, Turnbull PC et al (2019) Early myopathy in Duchenne muscular dystrophy is associated with elevated mitochondrial H2 O2 emission during impaired oxidative phosphorylation. J Cachexia Sarcopenia Muscle 10(3):643\u2013661. https:\/\/doi.org\/10.1002\/jcsm.12405","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"3821_CR34","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/978-1-4020-6191-2_16","volume":"45","author":"FW Hopf","year":"2007","unstructured":"Hopf FW, Turner PR, Steinhardt RA (2007) Calcium misregulation and the pathogenesis of muscular dystrophy. Subcell Biochem 45:429\u2013464. https:\/\/doi.org\/10.1007\/978-1-4020-6191-2_16","journal-title":"Subcell Biochem"},{"issue":"6","key":"3821_CR35","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10974-015-9438-9","volume":"36","author":"M Kozakowska","year":"2015","unstructured":"Kozakowska M, Pietraszek-Gremplewicz K, Jozkowicz A, Dulak J (2015) The role of oxidative stress in skeletal muscle injury and regeneration: focus on antioxidant enzymes. J Muscle Res Cell Motil 36(6):377\u2013393. https:\/\/doi.org\/10.1007\/s10974-015-9438-9","journal-title":"J Muscle Res Cell Motil"},{"key":"3821_CR36","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1242\/jcs.02857","volume":"119","author":"LM Judge","year":"2006","unstructured":"Judge LM, Haraguchi M, Chamberlain JS (2006) Dissecting the signalling and mechanical functions of the dystrophin-glycoprotein complex. J Cell Sci 119:1537\u20131546. https:\/\/doi.org\/10.1242\/jcs.02857","journal-title":"J Cell Sci"},{"key":"3821_CR37","doi-asserted-by":"publisher","first-page":"113086","DOI":"10.1016\/j.expneurol.2019.113086","volume":"323","author":"C Sun","year":"2020","unstructured":"Sun C, Serra C, Lee G, Wagner KR (2020) Stem cell-based therapies for Duchenne muscular dystrophy. Exp Neurol 323:113086. https:\/\/doi.org\/10.1016\/j.expneurol.2019.113086","journal-title":"Exp Neurol"},{"key":"3821_CR38","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/00005072-199903000-00003","volume":"58","author":"AO Gramolini","year":"1999","unstructured":"Gramolini AO, Karpati G, Jasmin BJ (1999) Discordant expression of utrophin and its transcript in human and mouse skeletal muscles. J Neuropathol Exp Neurol 58:235\u2013244. https:\/\/doi.org\/10.1097\/00005072-199903000-00003","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"3821_CR39","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1750-3639.1996.tb00781.x","volume":"6","author":"DJ Blake","year":"1996","unstructured":"Blake DJ, Tinsley JM, Davies KE (1996) Utrophin: a structural and functional comparison to dystrophin. Brain Pathol 6(1):37\u201347. https:\/\/doi.org\/10.1111\/j.1750-3639.1996.tb00781.x","journal-title":"Brain Pathol"},{"key":"3821_CR40","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1080\/21678707.2018.1438261","volume":"6","author":"S Guiraud","year":"2018","unstructured":"Guiraud S, Roblin D, Kay DE (2018) The potential of utrophin modulators for the treatment of Duchenne muscular dystrophy. Expert Opin Orphan Drugs 6:179\u2013192. https:\/\/doi.org\/10.1080\/21678707.2018.1438261","journal-title":"Expert Opin Orphan Drugs"},{"issue":"2","key":"3821_CR41","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s10974-015-9406-4","volume":"36","author":"J Manning","year":"2015","unstructured":"Manning J, O\u2019Malley D (2015) What has the mdx mouse model of Duchenne muscular dystrophy contributed to our understanding of this disease? J Muscle Res Cell Motil 36(2):155\u2013167. https:\/\/doi.org\/10.1007\/s10974-015-9406-4","journal-title":"J Muscle Res Cell Motil"},{"issue":"9","key":"3821_CR42","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1096\/fj.06-7353com","volume":"21","author":"JS Chamberlain","year":"2007","unstructured":"Chamberlain JS, Metzger J, Reyes M, Townsend D, Faulkner JA (2007) Dystrophin-deficient mdx mice display a reduced life span and are susceptible to spontaneous rhabdomyosarcoma. FASEB J 21(9):2195\u20132204. https:\/\/doi.org\/10.1096\/fj.06-7353com","journal-title":"FASEB J"},{"issue":"4","key":"3821_CR43","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/s0092-8674(00)80532-2","volume":"90","author":"AE Deconinck","year":"1997","unstructured":"Deconinck AE, Rafael JA, Skinner JA et al (1997) Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy. Cell 90(4):717\u2013727. https:\/\/doi.org\/10.1016\/s0092-8674(00)80532-2","journal-title":"Cell"},{"issue":"4","key":"3821_CR44","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/s0092-8674(00)80533-4","volume":"90","author":"RM Grady","year":"1997","unstructured":"Grady RM, Teng H, Nichol MC, Cunningham JC, Wilkinson RS, Sanes JR (1997) Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy. Cell 90(4):729\u2013738. https:\/\/doi.org\/10.1016\/s0092-8674(00)80533-4","journal-title":"Cell"},{"issue":"3","key":"3821_CR45","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1242\/dmm.018424","volume":"8","author":"JW McGreevy","year":"2015","unstructured":"McGreevy JW, Hakim CH, McIntosh MA, Duan D (2015) Animal models of Duchenne muscular dystrophy: from basic mechanisms to gene therapy. Dis Model Mech 8(3):195\u2013213. https:\/\/doi.org\/10.1242\/dmm.018424","journal-title":"Dis Model Mech"},{"key":"3821_CR46","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.molmed.2016.04.002","volume":"22","author":"NC Chang","year":"2016","unstructured":"Chang NC, Chevalier FP, Rudnicki MA (2016) Satellite cells in muscular dystrophy - lost in polarity. Trends Mol Med 22:479\u2013496. https:\/\/doi.org\/10.1016\/j.molmed.2016.04.002","journal-title":"Trends Mol Med"},{"key":"3821_CR47","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1007\/s00018-019-03006-7","volume":"76","author":"P Podkalicka","year":"2019","unstructured":"Podkalicka P, Mucha O, Dulak J, Loboda A (2019) Targeting angiogenesis in Duchenne muscular dystrophy. Cell Mol Life Sci 76:1507\u20131528. https:\/\/doi.org\/10.1007\/s00018-019-03006-7","journal-title":"Cell Mol Life Sci"},{"key":"3821_CR48","doi-asserted-by":"publisher","first-page":"R163","DOI":"10.1093\/hmg\/ddy171","volume":"27","author":"L Echevarr\u00eda","year":"2018","unstructured":"Echevarr\u00eda L, Aupy P, Goyenvalle A (2018) Exon-skipping advances for Duchenne muscular dystrophy. Hum Mol Genet 27:R163\u2013R172. https:\/\/doi.org\/10.1093\/hmg\/ddy171","journal-title":"Hum Mol Genet"},{"key":"3821_CR49","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1146\/annurev-med-081117-010451","volume":"70","author":"YL Min","year":"2019","unstructured":"Min YL, Bassel-Duby R, Olson EN (2019) CRISPR correction of duchenne muscular dystrophy. Annu Rev Med 70:239\u2013255. https:\/\/doi.org\/10.1146\/annurev-med-081117-010451","journal-title":"Annu Rev Med"},{"key":"3821_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/15476286.2021.1874161","volume":"20","author":"B Hanson","year":"2021","unstructured":"Hanson B, Wood MJA, Roberts TC (2021) Molecular correction of Duchenne muscular dystrophy by splice modulation and gene editing. RNA Biol 20:1\u201315. https:\/\/doi.org\/10.1080\/15476286.2021.1874161","journal-title":"RNA Biol"},{"issue":"2","key":"3821_CR51","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1080\/13543784.2021.1868434","volume":"30","author":"O Sheikh","year":"2021","unstructured":"Sheikh O, Yokota T (2021) Developing DMD therapeutics: a review of the effectiveness of small molecules, stop-codon readthrough, dystrophin gene replacement, and exon-skipping therapies. Expert Opin Investig Drugs 30(2):167\u2013176. https:\/\/doi.org\/10.1080\/13543784.2021.1868434","journal-title":"Expert Opin Investig Drugs"},{"key":"3821_CR52","doi-asserted-by":"crossref","unstructured":"Rodrigues M, Yokota T (2018) An overview of recent advances and clinical applications of exon skipping and splice modulation for muscular dystrophy and various genetic diseases. In: Yokota T, Maruyama R (ed) Exon Skipping and Inclusion Therapies. Methods in Molecular Biology, vol 1828. Humana Press, New York","DOI":"10.1007\/978-1-4939-8651-4_2"},{"key":"3821_CR53","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.ymthe.2017.02.019","volume":"25","author":"JR Chamberlain","year":"2017","unstructured":"Chamberlain JR, Chamberlain JS (2017) Progress toward gene therapy for Duchenne muscular dystrophy. Mol Ther 25:1125\u20131131. https:\/\/doi.org\/10.1016\/j.ymthe.2017.02.019","journal-title":"Mol Ther"},{"issue":"9","key":"3821_CR54","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1001\/jamaneurol.2020.1484","volume":"77","author":"JR Mendell","year":"2020","unstructured":"Mendell JR, Sahenk Z, Lehman K et al (2020) Assessment of systemic delivery of rAAVrh74.MHCK7.micro-dystrophin in children with duchenne muscular dystrophy: a nonrandomized controlled trial. JAMA Neurol 77(9):1122\u20131131. https:\/\/doi.org\/10.1001\/jamaneurol.2020.1484","journal-title":"JAMA Neurol"},{"issue":"1","key":"3821_CR55","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1089\/hum.2011.131","volume":"23","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Duan D (2012) Novel mini-dystrophin gene dual adeno-associated virus vectors restore neuronal nitric oxide synthase expression at the sarcolemma. Hum Gene Ther 23(1):98\u2013103. https:\/\/doi.org\/10.1089\/hum.2011.131","journal-title":"Hum Gene Ther"},{"issue":"3","key":"3821_CR56","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1089\/hum.2017.095","volume":"29","author":"K Kodippili","year":"2018","unstructured":"Kodippili K, Hakim CH, Pan X et al (2018) AAV gene therapy for duchenne muscular dystrophy with a 7-kb mini-dystrophin gene in the canine model. Hum Gene Ther 29(3):299\u2013311. https:\/\/doi.org\/10.1089\/hum.2017.095","journal-title":"Hum Gene Ther"},{"key":"3821_CR57","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1007\/s43440-020-00134-x","volume":"72","author":"A \u0141oboda","year":"2020","unstructured":"\u0141oboda A, Dulak J (2020) Muscle and cardiac therapeutic strategies for Duchenne muscular dystrophy: past, present, and future. Pharmacol Rep 72:1227\u20131263. https:\/\/doi.org\/10.1007\/s43440-020-00134-x","journal-title":"Pharmacol Rep"},{"issue":"12","key":"3821_CR58","doi-asserted-by":"publisher","first-page":"253","DOI":"10.3390\/cells7120253","volume":"7","author":"L Danisovic","year":"2018","unstructured":"Danisovic L, Culenova M, Csobonyeiova M (2018) Induced pluripotent stem cells for duchenne muscular dystrophy modeling and therapy. Cells 7(12):253. https:\/\/doi.org\/10.3390\/cells7120253","journal-title":"Cells"},{"key":"3821_CR59","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.csbj.2020.03.012","volume":"18","author":"Y Jin","year":"2020","unstructured":"Jin Y, Shen Y, Su X, Weintraub NL, Tang Y (2020) Effective restoration of dystrophin expression in iPSC Mdx-derived muscle progenitor cells using the CRISPR\/Cas9 system and homology-directed repair technology. Comput Struct Biotechnol J 18:765\u2013773. https:\/\/doi.org\/10.1016\/j.csbj.2020.03.012","journal-title":"Comput Struct Biotechnol J"},{"key":"3821_CR60","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.omtm.2018.10.005","volume":"11","author":"TL Kennedy","year":"2018","unstructured":"Kennedy TL, Guiraud S, Edwards B et al (2018) Micro-utrophin improves cardiac and skeletal muscle function of severely affected D2\/mdx mice. Mol Ther Methods Clin Dev 11:92\u2013105. https:\/\/doi.org\/10.1016\/j.omtm.2018.10.005","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"12","key":"3821_CR61","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1038\/4033","volume":"4","author":"J Tinsley","year":"1998","unstructured":"Tinsley J, Deconinck N, Fisher R, Kahn D, Phelps S, Gillis JM, Davies K (1998) Expression of full-length utrophin prevents muscular dystrophy in mdx mice. Nat Med 4(12):1441\u20131444. https:\/\/doi.org\/10.1038\/4033","journal-title":"Nat Med"},{"key":"3821_CR62","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1038\/mt.2008.149","volume":"16","author":"GL Odom","year":"2008","unstructured":"Odom GL, Gregorevic P, Allen JM et al (2008) Microutrophin delivery through rAAV6 increases lifespan and improves muscle function in dystrophic dystrophin\/Utrophin-deficient mice. Mol Ther 16:1539\u20131545. https:\/\/doi.org\/10.1038\/mt.2008.149","journal-title":"Mol Ther"},{"issue":"1","key":"3821_CR63","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/ng0598-79","volume":"19","author":"JA Rafael","year":"1998","unstructured":"Rafael JA, Tinsley JM, Potter AC, Deconinck AE, Davies KE (1998) Skeletal muscle-specific expression of a utrophin transgene rescues utrophin-dystrophin deficient mice. Nat Genet 19(1):79\u201382. https:\/\/doi.org\/10.1038\/ng0598-79","journal-title":"Nat Genet"},{"key":"3821_CR64","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1093\/hmg\/ddz049","volume":"28","author":"S Guiraud","year":"2019","unstructured":"Guiraud S, Edwards B, Babbs A et al (2019) The potential of utrophin and dystrophin combination therapies for duchenne muscular dystrophy. Hum Mol Genet 28:2189\u20132200. https:\/\/doi.org\/10.1093\/hmg\/ddz049","journal-title":"Hum Mol Genet"},{"key":"3821_CR65","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1242\/jcs.064808","volume":"123","author":"D Li","year":"2010","unstructured":"Li D, Bareja A, Judge L et al (2010) Sarcolemmal nNOS anchoring reveals a qualitative difference between dystrophin and utrophin. J Cell Sci 123:2008\u20132013. https:\/\/doi.org\/10.1242\/jcs.064808","journal-title":"J Cell Sci"},{"key":"3821_CR66","doi-asserted-by":"publisher","first-page":"5723","DOI":"10.1073\/pnas.1323842111","volume":"111","author":"JJ Belanto","year":"2014","unstructured":"Belanto JJ, Mader TL, Eckhoff MD et al (2014) Microtubule binding distinguishes dystrophin from utrophin. Proc Natl Acad Sci USA 111:5723\u20135728. https:\/\/doi.org\/10.1073\/pnas.1323842111","journal-title":"Proc Natl Acad Sci USA"},{"issue":"21","key":"3821_CR67","doi-asserted-by":"publisher","first-page":"4299","DOI":"10.1007\/s00018-020-03537-4","volume":"77","author":"R Brusa","year":"2020","unstructured":"Brusa R, Magri F, Bresolin N, Comi GP, Corti S (2020) Noncoding RNAs in Duchenne and Becker muscular dystrophies: role in pathogenesis and future prognostic and therapeutic perspectives. Cell Mol Life Sci 77(21):4299\u20134313. https:\/\/doi.org\/10.1007\/s00018-020-03537-4","journal-title":"Cell Mol Life Sci"},{"key":"3821_CR68","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.matbio.2018.07.003","volume":"74","author":"S Zanotti","year":"2018","unstructured":"Zanotti S, Gibertini S, Blasevich F et al (2018) Exosomes and exosomal miRNAs from muscle-derived fibroblasts promote skeletal muscle fibrosis. Matrix Biol 74:77\u2013100. https:\/\/doi.org\/10.1016\/j.matbio.2018.07.003","journal-title":"Matrix Biol"},{"issue":"11","key":"3821_CR69","doi-asserted-by":"publisher","first-page":"dmm045559","DOI":"10.1242\/dmm.045559","volume":"13","author":"M Gartz","year":"2020","unstructured":"Gartz M, Lin CW, Sussman MA, Lawlor MW, Strande JL (2020) Duchenne muscular dystrophy (DMD) cardiomyocyte-secreted exosomes promote the pathogenesis of DMD-associated cardiomyopathy. Dis Model Mech 13(11):dmm045559. https:\/\/doi.org\/10.1242\/dmm.045559","journal-title":"Dis Model Mech"},{"key":"3821_CR70","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1002\/cphy.c100092","volume":"1","author":"JG Tidball","year":"2011","unstructured":"Tidball JG (2011) Mechanisms of muscle injury, repair, and regeneration. Compr Physiol 1:2029\u20132062. https:\/\/doi.org\/10.1002\/cphy.c100092","journal-title":"Compr Physiol"},{"key":"3821_CR71","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s11914-018-0468-2","volume":"16","author":"A Boulanger Piette","year":"2018","unstructured":"Boulanger Piette A, Hamoudi D, Marcadet L et al (2018) Targeting the muscle-bone unit: filling two needs with one deed in the treatment of Duchenne muscular dystrophy. Curr Osteoporos Rep 16:541\u2013553. https:\/\/doi.org\/10.1007\/s11914-018-0468-2","journal-title":"Curr Osteoporos Rep"},{"key":"3821_CR72","doi-asserted-by":"publisher","first-page":"381","DOI":"10.3389\/fphys.2013.00381","volume":"4","author":"GD Thomas","year":"2013","unstructured":"Thomas GD (2013) Functional muscle ischemia in Duchenne and Becker muscular dystrophy. Front Physiol 4:381. https:\/\/doi.org\/10.3389\/fphys.2013.00381","journal-title":"Front Physiol"},{"key":"3821_CR73","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1016\/j.celrep.2019.04.074","volume":"27","author":"MN Wosczyna","year":"2020","unstructured":"Wosczyna MN, Konishi CT, Carbajal EEP et al (2020) Mesenchymal stromal cells are required for regeneration and homeostatic maintenance of skeletal muscle. Cell Rep 27:2029-2035.e5. https:\/\/doi.org\/10.1016\/j.celrep.2019.04.074","journal-title":"Cell Rep"},{"key":"3821_CR74","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/nature07201","volume":"454","author":"R Medzhitov","year":"2008","unstructured":"Medzhitov R (2008) Origin and physiological roles of inflammation. Nature 454:428\u2013435. https:\/\/doi.org\/10.1038\/nature07201","journal-title":"Nature"},{"key":"3821_CR75","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3389\/fimmu.2014.00461","volume":"5","author":"T Kawasaki","year":"2014","unstructured":"Kawasaki T, Kawai T (2014) Toll-like receptor signaling pathways. Front Immunol 5:461. https:\/\/doi.org\/10.3389\/fimmu.2014.00461","journal-title":"Front Immunol"},{"issue":"10","key":"3821_CR76","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1093\/hmg\/ddt656","volume":"23","author":"A Henriques-Pons","year":"2014","unstructured":"Henriques-Pons A, Yu Q, Rayavarapu S et al (2014) Role of Toll-like receptors in the pathogenesis of dystrophin-deficient skeletal and heart muscle. Hum Mol Genet 23(10):2604\u20132617. https:\/\/doi.org\/10.1093\/hmg\/ddt656","journal-title":"Hum Mol Genet"},{"key":"3821_CR77","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1016\/j.bbamcr.2014.05.014","volume":"1843","author":"MD Turner","year":"2014","unstructured":"Turner MD, Nedjai B, Hurst T, Pennington DJ (2014) Cytokines and chemokines: at the crossroads of cell signalling and inflammatory disease. Biochim Biophys Acta Mol Cell Res 1843:2563\u20132582. https:\/\/doi.org\/10.1016\/j.bbamcr.2014.05.014","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"issue":"9","key":"3821_CR78","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.7150\/ijbs.4989","volume":"8","author":"S Rose-John","year":"2012","unstructured":"Rose-John S (2012) IL-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory activities of IL-6. Int J Biol Sci 8(9):1237\u20131247. https:\/\/doi.org\/10.7150\/ijbs.4989","journal-title":"Int J Biol Sci"},{"issue":"4","key":"3821_CR79","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.ebiom.2015.02.014","volume":"2","author":"L Pelosi","year":"2015","unstructured":"Pelosi L, Berardinelli MG, De Pasquale L et al (2015) Functional and morphological improvement of dystrophic muscle by interleukin 6 receptor blockade. EBioMedicine 2(4):285\u2013293. https:\/\/doi.org\/10.1016\/j.ebiom.2015.02.014","journal-title":"EBioMedicine"},{"key":"3821_CR80","doi-asserted-by":"publisher","first-page":"3449","DOI":"10.1093\/hmg\/ddy258","volume":"27","author":"YS Gallot","year":"2018","unstructured":"Gallot YS, Straughn AR, Bohnert KR et al (2018) MyD88 is required for satellite cell-mediated myofiber regeneration in dystrophin-deficient mdx mice. Hum Mol Genet 27:3449\u20133463. https:\/\/doi.org\/10.1093\/hmg\/ddy258","journal-title":"Hum Mol Genet"},{"key":"3821_CR81","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/cphy.c170052","volume":"8","author":"JG Tidball","year":"2018","unstructured":"Tidball JG, Welc SS, Wehling-Henricks M (2018) Immunobiology of inherited muscular dystrophies. Compr Physiol 8:1313\u20131356. https:\/\/doi.org\/10.1002\/cphy.c170052","journal-title":"Compr Physiol"},{"key":"3821_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10974-012-9330-9","volume":"34","author":"J-H Kim","year":"2013","unstructured":"Kim J-H, Kwak H-B, Thompson LV, Lawler JM (2013) Contribution of oxidative stress to pathology in diaphragm and limb muscles with Duchenne muscular dystrophy. J Muscle Res Cell Motil 34:1\u201313. https:\/\/doi.org\/10.1007\/s10974-012-9330-9","journal-title":"J Muscle Res Cell Motil"},{"key":"3821_CR83","doi-asserted-by":"publisher","first-page":"299rv4","DOI":"10.1126\/scitranslmed.aaa7322","volume":"7","author":"AS Rosenberg","year":"2015","unstructured":"Rosenberg AS, Puig M, Nagaraju K et al (2015) Immune-mediated pathology in Duchenne muscular dystrophy. Sci Transl Med 7:299rv4. https:\/\/doi.org\/10.1126\/scitranslmed.aaa7322","journal-title":"Sci Transl Med"},{"key":"3821_CR84","doi-asserted-by":"publisher","first-page":"e72121","DOI":"10.1371\/journal.pone.0072121","volume":"8","author":"SM Hindi","year":"2013","unstructured":"Hindi SM, Shin J, Ogura Y et al (2013) Matrix metalloproteinase-9 inhibition improves proliferation and engraftment of myogenic cells in dystrophic muscle of mdx mice. PLoS ONE 8:e72121. https:\/\/doi.org\/10.1371\/journal.pone.0072121","journal-title":"PLoS ONE"},{"key":"3821_CR85","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.nmd.2011.05.011","volume":"21","author":"VD Nadarajah","year":"2011","unstructured":"Nadarajah VD, van Putten M, Chaouch A et al (2011) Serum matrix metalloproteinase-9 (MMP-9) as a biomarker for monitoring disease progression in Duchenne muscular dystrophy (DMD). Neuromuscul Disord 21:569\u2013578. https:\/\/doi.org\/10.1016\/j.nmd.2011.05.011","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"3821_CR86","doi-asserted-by":"publisher","first-page":"3655","DOI":"10.1038\/s41467-018-06057-9","volume":"9","author":"JE Morgan","year":"2018","unstructured":"Morgan JE, Prola A, Mariot V et al (2018) Necroptosis mediates myofibre death in dystrophin-deficient mice. Nat Commun 9(1):3655. https:\/\/doi.org\/10.1038\/s41467-018-06057-9","journal-title":"Nat Commun"},{"key":"3821_CR87","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1172\/JCI30556","volume":"117","author":"S Acharyya","year":"2007","unstructured":"Acharyya S, Villalta SA, Bakkar N et al (2007) Interplay of IKK\/NF- k B signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy. J Clin Invest 117:889\u2013901","journal-title":"J Clin Invest"},{"key":"3821_CR88","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1038\/gt.2011.207","volume":"19","author":"Q Yang","year":"2012","unstructured":"Yang Q, Tang Y, Imbrogno K et al (2012) AAV-based shRNA silencing of NF-\u03baB ameliorates muscle pathologies in mdx mice. Gene Ther 19:1196\u20131204. https:\/\/doi.org\/10.1038\/gt.2011.207","journal-title":"Gene Ther"},{"key":"3821_CR89","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1002\/mus.25517","volume":"56","author":"X Yin","year":"2017","unstructured":"Yin X, Tang Y, Li J et al (2017) Genetic ablation of P65 subunit of NF-\u03baB in mdx mice to improve muscle physiological function. Muscle Nerve 56:759\u2013767. https:\/\/doi.org\/10.1002\/mus.25517","journal-title":"Muscle Nerve"},{"key":"3821_CR90","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1093\/hmg\/ddz124","volume":"28","author":"D Hamoudi","year":"2019","unstructured":"Hamoudi D, Marcadet L, Piette AB et al (2019) An anti-RANKL treatment reduces muscle inflammation and dysfunction and strengthens bone in dystrophic mice. Hum Mol Genet 28:3101\u20133112. https:\/\/doi.org\/10.1093\/hmg\/ddz124","journal-title":"Hum Mol Genet"},{"key":"3821_CR91","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/hmg\/ddx380","volume":"27","author":"M Wehling-Henricks","year":"2018","unstructured":"Wehling-Henricks M, Welc SS, Samengo G et al (2018) Macrophages escape Klotho gene silencing in the mdx mouse model of Duchenne muscular dystrophy and promote muscle growth and increase satellite cell numbers through a Klotho-mediated pathway. Hum Mol Genet 27:14\u201329. https:\/\/doi.org\/10.1093\/hmg\/ddx380","journal-title":"Hum Mol Genet"},{"key":"3821_CR92","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1093\/hmg\/ddw111","volume":"25","author":"M Wehling-Henricks","year":"2016","unstructured":"Wehling-Henricks M, Li Z, Lindsey C et al (2016) Klotho gene silencing promotes pathology in the mdx mouse model of Duchenne muscular dystrophy. Hum Mol Genet 25:2465\u20132482. https:\/\/doi.org\/10.1093\/hmg\/ddw111","journal-title":"Hum Mol Genet"},{"key":"3821_CR93","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1002\/jbmr.410","volume":"26","author":"A Rufo","year":"2011","unstructured":"Rufo A, Del Fattore A, Capulli M et al (2011) Mechanisms inducing low bone density in duchenne muscular dystrophy in mice and humans. J Bone Miner Res 26:1891\u20131903. https:\/\/doi.org\/10.1002\/jbmr.410","journal-title":"J Bone Miner Res"},{"key":"3821_CR94","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/bonekey.2012.5","volume":"1","author":"VH Morgenroth","year":"2012","unstructured":"Morgenroth VH, Hache LP, Clemens PR (2012) Insights into bone health in Duchenne muscular dystrophy. Bonekey Rep 1:9. https:\/\/doi.org\/10.1038\/bonekey.2012.5","journal-title":"Bonekey Rep"},{"issue":"19","key":"3821_CR95","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1212\/01.wnl.0000260974.41514.83","volume":"68","author":"WM King","year":"2007","unstructured":"King WM, Ruttencutter R, Nagaraja HN, Matkovic V, Landoll J, Hoyle C, Mendell JR, Kissel JT (2007) Orthopedic outcomes of long-term daily corticosteroid treatment in Duchenne muscular dystrophy. Neurology 68(19):1607\u20131613. https:\/\/doi.org\/10.1212\/01.wnl.0000260974.41514.83","journal-title":"Neurology"},{"key":"3821_CR96","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/jor.22236","volume":"31","author":"C Isaac","year":"2013","unstructured":"Isaac C, Wright A, Usas A et al (2013) Dystrophin and utrophin \u201cdouble knockout\u201d dystrophic mice exhibit a spectrum of degenerative musculoskeletal abnormalities. J Orthop Res 31:343\u2013349. https:\/\/doi.org\/10.1002\/jor.22236","journal-title":"J Orthop Res"},{"key":"3821_CR97","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.nmd.2010.12.002","volume":"21","author":"SA Novotny","year":"2011","unstructured":"Novotny SA, Warren GL, Lin AS et al (2011) Bone is functionally impaired in dystrophic mice but less so than skeletal muscle. Neuromuscul Disord 21:183\u2013193. https:\/\/doi.org\/10.1016\/j.nmd.2010.12.002","journal-title":"Neuromuscul Disord"},{"key":"3821_CR98","doi-asserted-by":"publisher","first-page":"3619","DOI":"10.1096\/fj.13-233460","volume":"27","author":"X Mu","year":"2013","unstructured":"Mu X, Usas A, Tang Y et al (2013) RhoA mediates defective stem cell function and heterotopic ossification in dystrophic muscle of mice. FASEB J 27:3619\u20133631. https:\/\/doi.org\/10.1096\/fj.13-233460","journal-title":"FASEB J"},{"key":"3821_CR99","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.cmet.2007.11.011","volume":"7","author":"AL Serrano","year":"2008","unstructured":"Serrano AL, Baeza-Raja B, Perdiguero E et al (2008) Interleukin-6 is an essential regulator of satellite cell-mediated skeletal muscle hypertrophy. Cell Metab 7:33\u201344. https:\/\/doi.org\/10.1016\/j.cmet.2007.11.011","journal-title":"Cell Metab"},{"issue":"21","key":"3821_CR100","doi-asserted-by":"publisher","first-page":"6041","DOI":"10.1093\/hmg\/ddv323","volume":"24","author":"L Pelosi","year":"2015","unstructured":"Pelosi L, Berardinelli MG, Forcina L et al (2015) Increased levels of interleukin-6 exacerbate the dystrophic phenotype in mdx mice. Hum Mol Genet 24(21):6041\u20136053. https:\/\/doi.org\/10.1093\/hmg\/ddv323","journal-title":"Hum Mol Genet"},{"key":"3821_CR101","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1002\/jcb.24777","volume":"115","author":"K Matsushita","year":"2014","unstructured":"Matsushita K, Itoh S, Ikeda S et al (2014) LIF\/STAT3\/SOCS3 signaling pathway in murine bone marrow stromal cells suppresses osteoblast differentiation. J Cell Biochem 115:1262\u20131268. https:\/\/doi.org\/10.1002\/jcb.24777","journal-title":"J Cell Biochem"},{"key":"3821_CR102","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1172\/JCI37662","volume":"119","author":"SA Vetrone","year":"2009","unstructured":"Vetrone SA, Montecino-Rodriguez E, Kudryashova E et al (2009) Osteopontin promotes fibrosis in dystrophic mouse muscle by modulating immune cell subsets and intramuscular TGF-\u03b2. J Clin Invest 119:1583\u20131594. https:\/\/doi.org\/10.1172\/JCI37662","journal-title":"J Clin Invest"},{"key":"3821_CR103","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1212\/WNL.0b013e3182518302","volume":"78","author":"L De Pasquale","year":"2012","unstructured":"De Pasquale L, D\u2019Amico A, Verardo M et al (2012) Increased muscle expression of interleukin-17 in Duchenne muscular dystrophy. Neurology 78:1309\u20131314. https:\/\/doi.org\/10.1212\/WNL.0b013e3182518302","journal-title":"Neurology"},{"key":"3821_CR104","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1002\/mus.26195","volume":"58","author":"S Zhou","year":"2018","unstructured":"Zhou S, Qian B, Wang L et al (2018) Altered bone-regulating myokine expression in skeletal muscle of Duchenne muscular dystrophy mouse models. Muscle Nerve 58:573\u2013582. https:\/\/doi.org\/10.1002\/mus.26195","journal-title":"Muscle Nerve"},{"key":"3821_CR105","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/S0002-9440(10)62333-4","volume":"166","author":"LJ Harcourt","year":"2005","unstructured":"Harcourt LJ, Holmes AG, Gregorevic P et al (2005) Interleukin-15 administration improves diaphragm muscle pathology and function in dystrophic mdx mice. Am J Pathol 166:1131\u20131141. https:\/\/doi.org\/10.1016\/S0002-9440(10)62333-4","journal-title":"Am J Pathol"},{"key":"3821_CR106","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.devcel.2005.02.017","volume":"8","author":"DA Glass II","year":"2005","unstructured":"Glass DA II, Bialek P, Ahn JD et al (2005) Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev Cell 8:751\u2013764. https:\/\/doi.org\/10.1016\/j.devcel.2005.02.017","journal-title":"Dev Cell"},{"issue":"8","key":"3821_CR107","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1073\/pnas.1200797109","volume":"109","author":"W Wei","year":"2012","unstructured":"Wei W, Dutchak PA, Wang X et al (2012) Fibroblast growth factor 21 promotes bone loss by potentiating the effects of peroxisome proliferator-activated receptor \u03b3. Proc Natl Acad Sci USA 109(8):3143\u20133148. https:\/\/doi.org\/10.1073\/pnas.1200797109","journal-title":"Proc Natl Acad Sci USA"},{"key":"3821_CR108","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1038\/nm.3917","volume":"21","author":"B Dankbar","year":"2015","unstructured":"Dankbar B, Fennen M, Brunert D et al (2015) Myostatin is a direct regulator of osteoclast differentiation and its inhibition reduces inflammatory joint destruction in mice. Nat Med 21:1085\u20131090. https:\/\/doi.org\/10.1038\/nm.3917","journal-title":"Nat Med"},{"key":"3821_CR109","doi-asserted-by":"publisher","first-page":"13809","DOI":"10.1074\/jbc.M117.782128","volume":"292","author":"BC Goh","year":"2017","unstructured":"Goh BC, Singhal V, Herrera AJ et al (2017) Activin receptor type 2A (ACVR2A) functions directly in osteoblasts as a negative regulator of bone mass. J Biol Chem 292:13809\u201313822. https:\/\/doi.org\/10.1074\/jbc.M117.782128","journal-title":"J Biol Chem"},{"key":"3821_CR110","doi-asserted-by":"publisher","first-page":"4318","DOI":"10.1073\/pnas.0709144105","volume":"105","author":"AM Haidet","year":"2008","unstructured":"Haidet AM, Rizo L, Handy C et al (2008) Long-term enhancement of skeletal muscle mass and strength by single gene administration of myostatin inhibitors. Proc Natl Acad Sci USA 105:4318\u20134322. https:\/\/doi.org\/10.1073\/pnas.0709144105","journal-title":"Proc Natl Acad Sci USA"},{"key":"3821_CR111","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13395-018-0180-z","volume":"8","author":"A Iskenderian","year":"2018","unstructured":"Iskenderian A, Liu N, Deng Q et al (2018) Myostatin and activin blockade by engineered follistatin results in hypertrophy and improves dystrophic pathology in mdx mouse more than myostatin blockade alone. Skelet Muscle 8:34. https:\/\/doi.org\/10.1186\/s13395-018-0180-z","journal-title":"Skelet Muscle"},{"key":"3821_CR112","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.ajpath.2011.04.008","volume":"179","author":"J Zhu","year":"2011","unstructured":"Zhu J, Li Y, Lu A et al (2011) Follistatin improves skeletal muscle healing after injury and disease through an interaction with muscle regeneration, angiogenesis, and fibrosis. Am J Pathol 179:915\u2013930. https:\/\/doi.org\/10.1016\/j.ajpath.2011.04.008","journal-title":"Am J Pathol"},{"key":"3821_CR113","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1073\/pnas.0707069105","volume":"105","author":"CL Mendias","year":"2008","unstructured":"Mendias CL, Bakhurin KI, Faulkner JA (2008) Tendons of myostatin-deficient mice are small, brittle, and hypocellular. Proc Natl Acad Sci USA 105:388\u2013393. https:\/\/doi.org\/10.1073\/pnas.0707069105","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"3821_CR114","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/BF00314217","volume":"236","author":"D Cros","year":"1989","unstructured":"Cros D, Harnden P, Pellissier JF, Serratrice G (1989) Muscle hypertrophy in Duchenne muscular dystrophy. A pathological and morphometric study. J Neurol 236(1):43\u201347. https:\/\/doi.org\/10.1007\/BF00314217","journal-title":"J Neurol"},{"key":"3821_CR115","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/jemt.22448","volume":"78","author":"AA De Aro","year":"2015","unstructured":"De Aro AA, Da R\u00e9 GF, Marretto Esquisatto MA et al (2015) Biochemical and morphological alterations in the Achilles tendon of mdx mice. Microsc Res Tech 78:85\u201393. https:\/\/doi.org\/10.1002\/jemt.22448","journal-title":"Microsc Res Tech"},{"key":"3821_CR116","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1016\/j.jbiomech.2009.06.041","volume":"42","author":"E Rizzuto","year":"2009","unstructured":"Rizzuto E, Musar\u00f2 A, Catizone A, Del Prete Z (2009) Measuring tendon properties in mdx mice: cell viability and viscoelastic characteristics. J Biomech 42:2243\u20132248. https:\/\/doi.org\/10.1016\/j.jbiomech.2009.06.041","journal-title":"J Biomech"},{"key":"3821_CR117","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1006\/exmp.1994.1025","volume":"61","author":"JC Ridge","year":"1994","unstructured":"Ridge JC, Tidball JG, Ahl K et al (1994) Modifications in myotendinous junction surface morphology in dystrophin-deficient mouse muscle. Exp Mol Pathol 61:58\u201368","journal-title":"Exp Mol Pathol"},{"key":"3821_CR118","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1242\/jcs.107.6.1477","volume":"107","author":"DJ Law","year":"1994","unstructured":"Law DJ, Allen DL, Tidball JG (1994) Talin, vinculin and DRP (utrophin) concentrations are increased at mdx myotendinous junctions following onset of necrosis. J Cell Sci 107:1477\u20131483","journal-title":"J Cell Sci"},{"key":"3821_CR119","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.2353\/ajpath.2009.090052","volume":"175","author":"JV Welser","year":"2009","unstructured":"Welser JV, Rooney JE, Cohen NC et al (2009) Myotendinous junction defects and reduced force transmission in mice that lack \u03b17 integrin and utrophin. Am J Pathol 175:1545\u20131554. https:\/\/doi.org\/10.2353\/ajpath.2009.090052","journal-title":"Am J Pathol"},{"key":"3821_CR120","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/j.1469-8749.1975.tb03511.x","volume":"17","author":"GM Fenichel","year":"1975","unstructured":"Fenichel GM (1975) On the pathogenesis of Duchenne muscular dystrophy. Dev Med Child Neurol 17:527\u2013533. https:\/\/doi.org\/10.1111\/j.1469-8749.1975.tb03511.x","journal-title":"Dev Med Child Neurol"},{"issue":"1","key":"3821_CR121","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/83309","volume":"7","author":"RH Crosbie","year":"2001","unstructured":"Crosbie RH (2001) NO vascular control in Duchenne muscular dystrophy. Nat Med 7(1):27\u201329. https:\/\/doi.org\/10.1038\/83309","journal-title":"Nat Med"},{"key":"3821_CR122","doi-asserted-by":"publisher","first-page":"2978","DOI":"10.1093\/hmg\/ddy197","volume":"27","author":"ME Adams","year":"2018","unstructured":"Adams ME, Odom GL, Kim MJ et al (2018) Syntrophin binds directly to multiple spectrin-like repeats in dystrophin and mediates binding of nNOS to repeats 16\u201317. Hum Mol Genet 27:2978\u20132985. https:\/\/doi.org\/10.1093\/hmg\/ddy197","journal-title":"Hum Mol Genet"},{"key":"3821_CR123","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/nature07414","volume":"456","author":"YM Kobayashi","year":"2008","unstructured":"Kobayashi YM, Rader EP, Crawford RW et al (2008) Sarcolemma-localized nNOS is required to maintain activity after mild exercise. Nature 456:511\u2013515. https:\/\/doi.org\/10.1038\/nature07414","journal-title":"Nature"},{"key":"3821_CR124","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/2044-5040-3-9","volume":"3","author":"JP Ennen","year":"2013","unstructured":"Ennen JP, Verma M, Asakura A (2013) Vascular-targeted therapies for Duchenne muscular dystrophy. Skelet Muscle 3:9. https:\/\/doi.org\/10.1186\/2044-5040-3-9","journal-title":"Skelet Muscle"},{"issue":"1","key":"3821_CR125","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1096\/fasebj.13.1.9","volume":"13","author":"G Neufeld","year":"1999","unstructured":"Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z (1999) Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 13(1):9\u201322","journal-title":"FASEB J"},{"issue":"5","key":"3821_CR126","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1016\/j.ymthe.2004.08.007","volume":"10","author":"N Arsic","year":"2004","unstructured":"Arsic N, Zacchigna S, Zentilin L, Ramirez-Correa G, Pattarini L, Salvi A, Sinagra G, Giacca M (2004) Vascular endothelial growth factor stimulates skeletal muscle regeneration in vivo. Mol Ther 10(5):844\u2013854. https:\/\/doi.org\/10.1016\/j.ymthe.2004.08.007","journal-title":"Mol Ther"},{"issue":"6","key":"3821_CR127","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1172\/JCI62656","volume":"122","author":"N Liu","year":"2012","unstructured":"Liu N, Williams AH, Maxeiner JM et al (2012) microRNA-206 promotes skeletal muscle regeneration and delays progression of Duchenne muscular dystrophy in mice. J Clin Invest 122(6):2054\u20132065. https:\/\/doi.org\/10.1172\/JCI62656","journal-title":"J Clin Invest"},{"issue":"2","key":"3821_CR128","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1089\/152308602753666280","volume":"4","author":"J Dulak","year":"2002","unstructured":"Dulak J, J\u00f3zkowicz A, Foresti R et al (2002) Heme oxygenase activity modulates vascular endothelial growth factor synthesis in vascular smooth muscle cells. Antioxid Redox Signal 4(2):229\u2013240. https:\/\/doi.org\/10.1089\/152308602753666280","journal-title":"Antioxid Redox Signal"},{"issue":"3","key":"3821_CR129","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1084\/jem.20061609","volume":"204","author":"J Deshane","year":"2007","unstructured":"Deshane J, Chen S, Caballero S et al (2007) Stromal cell-derived factor 1 promotes angiogenesis via a heme oxygenase 1-dependent mechanism. J Exp Med 204(3):605\u2013618. https:\/\/doi.org\/10.1084\/jem.20061609","journal-title":"J Exp Med"},{"issue":"3","key":"3821_CR130","doi-asserted-by":"publisher","first-page":"e0174315","DOI":"10.1371\/journal.pone.0174315","volume":"12","author":"KM Gutpell","year":"2017","unstructured":"Gutpell KM, Tasevski N, Wong B et al (2017) ANG1 treatment reduces muscle pathology and prevents a decline in perfusion in DMD mice. PLoS ONE 12(3):e0174315. https:\/\/doi.org\/10.1371\/journal.pone.0174315","journal-title":"PLoS ONE"},{"key":"3821_CR131","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.bbrc.2013.09.085","volume":"440","author":"RP Rhoads","year":"2013","unstructured":"Rhoads RP, Flann KL, Cardinal TR et al (2013) Satellite cells isolated from aged or dystrophic muscle exhibit a reduced capacity to promote angiogenesis in vitro. Biochem Biophys Res Commun 440:399\u2013404. https:\/\/doi.org\/10.1016\/j.bbrc.2013.09.085","journal-title":"Biochem Biophys Res Commun"},{"issue":"21","key":"3821_CR132","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.1161\/01.CIR.0000147776.50787.74","volume":"110","author":"S Straino","year":"2004","unstructured":"Straino S, Germani A, Di Carlo A et al (2004) Enhanced arteriogenesis and wound repair in dystrophin-deficient mdx mice. Circulation 110(21):3341\u20133348. https:\/\/doi.org\/10.1161\/01.CIR.0000147776.50787.74","journal-title":"Circulation"},{"issue":"2","key":"3821_CR133","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.nmd.2004.11.002","volume":"15","author":"F Nguyen","year":"2005","unstructured":"Nguyen F, Guigand L, Goubault-Leroux I, Wyers M, Cherel Y (2005) Microvessel density in muscles of dogs with golden retriever muscular dystrophy. Neuromuscul Disord 15(2):154\u2013163. https:\/\/doi.org\/10.1016\/j.nmd.2004.11.002","journal-title":"Neuromuscul Disord"},{"key":"3821_CR134","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.stem.2018.09.007","volume":"23","author":"M Verma","year":"2018","unstructured":"Verma M, Asakura Y, Murakonda B et al (2018) Muscle satellite cell cross-talk with a vascular niche maintains quiescence via VEGF and notch signaling. Cell Stem Cell 23:530-543.e9. https:\/\/doi.org\/10.1016\/j.stem.2018.09.007","journal-title":"Cell Stem Cell"},{"key":"3821_CR135","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1097\/NEN.0b013e3181aa31c2","volume":"68","author":"I Desguerre","year":"2009","unstructured":"Desguerre I, Mayer M, Leturcq F et al (2009) Endomysial fibrosis in duchenne muscular dystrophy: a marker of poor outcome associated with macrophage alternative activation. J Neuropathol Exp Neurol 68:762\u2013773. https:\/\/doi.org\/10.1097\/NEN.0b013e3181aa31c2","journal-title":"J Neuropathol Exp Neurol"},{"key":"3821_CR136","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1016\/j.ajpath.2015.05.009","volume":"185","author":"C Latroche","year":"2015","unstructured":"Latroche C, Matot B, Martins-Bach A et al (2015) Structural and functional alterations of skeletal muscle microvasculature in Dystrophin-deficient mdx mice. Am J Pathol 185:2482\u20132494. https:\/\/doi.org\/10.1016\/j.ajpath.2015.05.009","journal-title":"Am J Pathol"},{"key":"3821_CR137","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3389\/fnagi.2014.00245","volume":"6","author":"A Birbrair","year":"2014","unstructured":"Birbrair A, Zhang T, Wang ZM et al (2014) Pericytes: Multitasking cells in the regeneration of injured, diseased, and aged skeletal muscle. Front Aging Neurosci 6:245. https:\/\/doi.org\/10.3389\/fnagi.2014.00245","journal-title":"Front Aging Neurosci"},{"key":"3821_CR138","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/ncb1542","volume":"9","author":"A Dellavalle","year":"2007","unstructured":"Dellavalle A, Sampaolesi M, Tonlorenzi R et al (2007) Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells. Nat Cell Biol 9:255\u2013267. https:\/\/doi.org\/10.1038\/ncb1542","journal-title":"Nat Cell Biol"},{"issue":"12","key":"3821_CR139","doi-asserted-by":"publisher","first-page":"e12357","DOI":"10.15252\/emmm.202012357","volume":"12","author":"S Choi","year":"2020","unstructured":"Choi S, Ferrari G, Tedesco FS (2020) Cellular dynamics of myogenic cell migration: molecular mechanisms and implications for skeletal muscle cell therapies. EMBO Mol Med 12(12):e12357. https:\/\/doi.org\/10.15252\/emmm.202012357","journal-title":"EMBO Mol Med"},{"issue":"Suppl 1","key":"3821_CR140","doi-asserted-by":"publisher","first-page":"S141","DOI":"10.3727\/096368914X685032","volume":"23","author":"D Skuk","year":"2014","unstructured":"Skuk D, Tremblay JP (2014) First study of intra-arterial delivery of myogenic mononuclear cells to skeletal muscles in primates. Cell Transplant 23(Suppl 1):S141\u2013S150. https:\/\/doi.org\/10.3727\/096368914X685032","journal-title":"Cell Transplant"},{"key":"3821_CR141","doi-asserted-by":"publisher","first-page":"14038","DOI":"10.1038\/mtm.2014.38","volume":"1","author":"AL Arnett","year":"2014","unstructured":"Arnett AL, Konieczny P, Ramos JN et al (2014) Adeno-associated viral (AAV) vectors do not efficiently target muscle satellite cells. Mol Ther Methods Clin Dev 1:14038. https:\/\/doi.org\/10.1038\/mtm.2014.38","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"6271","key":"3821_CR142","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1126\/science.aad5177","volume":"351","author":"M Tabebordbar","year":"2016","unstructured":"Tabebordbar M, Zhu K, Cheng JKW et al (2016) In vivo gene editing in dystrophic mouse muscle and muscle stem cells. Science 351(6271):407\u2013411. https:\/\/doi.org\/10.1126\/science.aad5177","journal-title":"Science"},{"key":"3821_CR143","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.cophys.2019.02.004","volume":"10","author":"MR Deschenes","year":"2019","unstructured":"Deschenes MR (2019) Adaptations of the neuromuscular junction to exercise training. Curr Opin Psychol 10:10\u201316. https:\/\/doi.org\/10.1016\/j.cophys.2019.02.004","journal-title":"Curr Opin Psychol"},{"key":"3821_CR144","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/mus.24095","volume":"49","author":"H Nishimune","year":"2014","unstructured":"Nishimune H, Stanford JA, Mori Y (2014) Role of exercise in maintaining the integrity of the neuromuscular junction. Muscle Nerve 49:315\u2013324. https:\/\/doi.org\/10.1002\/mus.24095","journal-title":"Muscle Nerve"},{"key":"3821_CR145","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3389\/fnagi.2014.00208","volume":"6","author":"M Gonzalez-Freire","year":"2014","unstructured":"Gonzalez-Freire M, de Cabo R, Studenski SA, Ferrucci L (2014) The neuromuscular junction: aging at the crossroad between nerves and muscle. Front Aging Neurosci 6:208. https:\/\/doi.org\/10.3389\/fnagi.2014.00208","journal-title":"Front Aging Neurosci"},{"key":"3821_CR146","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1113\/jphysiol.2012.241679","volume":"591","author":"SJP Pratt","year":"2013","unstructured":"Pratt SJP, Shah SB, Ward CW et al (2013) Effects of in vivo injury on the neuromuscular junction in healthy and dystrophic muscles. J Physiol 591:559\u2013570. https:\/\/doi.org\/10.1113\/jphysiol.2012.241679","journal-title":"J Physiol"},{"key":"3821_CR147","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s00018-014-1663-7","volume":"72","author":"SJP Pratt","year":"2015","unstructured":"Pratt SJP, Shah SB, Ward CW et al (2015) Recovery of altered neuromuscular junction morphology and muscle function in mdx mice after injury. Cell Mol Life Sci 72:153\u2013164. https:\/\/doi.org\/10.1007\/s00018-014-1663-7","journal-title":"Cell Mol Life Sci"},{"key":"3821_CR148","doi-asserted-by":"publisher","first-page":"103032","DOI":"10.1016\/j.ebiom.2020.103032","volume":"61","author":"SY Ng","year":"2020","unstructured":"Ng SY, Ljubicic V (2020) Recent insights into neuromuscular junction biology in Duchenne muscular dystrophy: impacts, challenges, and opportunities. EBioMedicine 61:103032. https:\/\/doi.org\/10.1016\/j.ebiom.2020.103032","journal-title":"EBioMedicine"},{"key":"3821_CR149","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/0022-510x(93)90190-a","volume":"119","author":"Y Mizuno","year":"1993","unstructured":"Mizuno Y, Nonaka I, Hirai S, Ozawa E (1993) Reciprocal expression of dystrophin and utrophin in muscles of Duchenne muscular dystrophy patients, female DMD-carriers and control subjects. J Neurol Sci 119:43\u201352. https:\/\/doi.org\/10.1016\/0022-510x(93)90190-a","journal-title":"J Neurol Sci"},{"key":"3821_CR150","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1083\/jcb.136.4.883","volume":"136","author":"AE Deconinck","year":"1997","unstructured":"Deconinck AE, Potter AC, Tinsley JM et al (1997) Postsynaptic abnormalities at the neuromuscular junctions of utrophin- deficient mice. J Cell Biol 136:883\u2013894. https:\/\/doi.org\/10.1083\/jcb.136.4.883","journal-title":"J Cell Biol"},{"key":"3821_CR151","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1111\/ejn.13249","volume":"43","author":"EM van der Pijl","year":"2016","unstructured":"van der Pijl EM, van Putten M, Niks EH et al (2016) Characterization of neuromuscular synapse function abnormalities in multiple Duchenne muscular dystrophy mouse models. Eur J Neurosci 43:1623\u20131635. https:\/\/doi.org\/10.1111\/ejn.13249","journal-title":"Eur J Neurosci"},{"issue":"1","key":"3821_CR152","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3233\/JND-180357","volume":"6","author":"A Aartsma-Rus","year":"2019","unstructured":"Aartsma-Rus A, Morgan J, Lonkar P et al (2019) Report of a TREAT-NMD\/World Duchenne Organisation meeting on Dystrophin quantification methodology. J Neuromuscul Dis 6(1):147\u2013159. https:\/\/doi.org\/10.3233\/JND-180357","journal-title":"J Neuromuscul Dis"},{"issue":"2","key":"3821_CR153","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s10974-019-09535-9","volume":"40","author":"DJ Wells","year":"2019","unstructured":"Wells DJ (2019) What is the level of dystrophin expression required for effective therapy of Duchenne muscular dystrophy? J Muscle Res Cell Motil 40(2):141\u2013150. https:\/\/doi.org\/10.1007\/s10974-019-09535-9","journal-title":"J Muscle Res Cell Motil"},{"key":"3821_CR154","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.nmd.2018.02.013","volume":"28","author":"EM van der Pijl","year":"2018","unstructured":"van der Pijl EM, van Putten M, Niks EH et al (2018) Low dystrophin levels are insufficient to normalize the neuromuscular synaptic abnormalities of mdx mice. Neuromuscul Disord 28:427\u2013442. https:\/\/doi.org\/10.1016\/j.nmd.2018.02.013","journal-title":"Neuromuscul Disord"},{"key":"3821_CR155","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1016\/j.bbadis.2018.01.030","volume":"1864","author":"C Pisani","year":"2018","unstructured":"Pisani C, Strimpakos G, Gabanella F et al (2018) Utrophin up-regulation by artificial transcription factors induces muscle rescue and impacts the neuromuscular junction in mdx mice. Biochim Biophys Acta Mol Basis Dis 1864:1172\u20131182. https:\/\/doi.org\/10.1016\/j.bbadis.2018.01.030","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"3821_CR156","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1083\/jcb.152.3.435","volume":"152","author":"C Jacobson","year":"2001","unstructured":"Jacobson C, C\u00f4t\u00e9 PD, Rossi SG et al (2001) The dystroglycan complex is necessary for stabilization of acetylcholine receptor clusters at neuromuscular junctions and formation of the synaptic basement membrane. J Cell Biol 152:435\u2013450. https:\/\/doi.org\/10.1083\/jcb.152.3.435","journal-title":"J Cell Biol"},{"issue":"4","key":"3821_CR157","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1083\/jcb.145.4.911","volume":"145","author":"HB Peng","year":"1999","unstructured":"Peng HB, Xie H, Rossi SG, Rotundo RL (1999) Acetylcholinesterase clustering at the neuromuscular junction involves perlecan and dystroglycan. J Cell Biol 145(4):911\u2013921. https:\/\/doi.org\/10.1083\/jcb.145.4.911","journal-title":"J Cell Biol"},{"key":"3821_CR158","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/s0092-8674(00)81251-9","volume":"85","author":"TM DeChiara","year":"1996","unstructured":"DeChiara TM, Bowen DC, Valenzuela DM et al (1996) The receptor tyrosine kinase MuSK is required for neuromuscular junction formation in vivo. Cell 85:501\u2013512. https:\/\/doi.org\/10.1016\/s0092-8674(00)81251-9","journal-title":"Cell"},{"key":"3821_CR159","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.mcn.2005.10.020","volume":"31","author":"BA Hesser","year":"2006","unstructured":"Hesser BA, Henschel O, Witzemann V (2006) Synapse disassembly and formation of new synapses in postnatal muscle upon conditional inactivation of MuSK. Mol Cell Neurosci 31:470\u2013480. https:\/\/doi.org\/10.1016\/j.mcn.2005.10.020","journal-title":"Mol Cell Neurosci"},{"key":"3821_CR160","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.biocel.2010.10.008","volume":"43","author":"N Ghazanfari","year":"2011","unstructured":"Ghazanfari N, Fernandez KJ, Murata Y et al (2011) Muscle specific kinase: organiser of synaptic membrane domains. Int J Biochem Cell Biol 43:295\u2013298. https:\/\/doi.org\/10.1016\/j.biocel.2010.10.008","journal-title":"Int J Biochem Cell Biol"},{"key":"3821_CR161","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1023\/B:NEUR.0000020619.24681.2b","volume":"32","author":"GB Banks","year":"2003","unstructured":"Banks GB, Fuhrer C, Adams ME, Froehner SC (2003) The postsynaptic submembrane machinery at the neuromuscular junction: requirement for rapsyn and the utrophin\/dystrophin-associated complex. J Neurocytol 32:709\u2013726. https:\/\/doi.org\/10.1023\/B:NEUR.0000020619.24681.2b","journal-title":"J Neurocytol"},{"key":"3821_CR162","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3389\/fphys.2013.00290","volume":"4","author":"R Rudolf","year":"2013","unstructured":"Rudolf R, Khan MM, Lustrino D, Labeit S, Kettelhut IC, Navegantes LC (2013) Alterations of cAMP-dependent signaling in dystrophic skeletal muscle. Front Physiol 4:290. https:\/\/doi.org\/10.3389\/fphys.2013.00290","journal-title":"Front Physiol"},{"issue":"3","key":"3821_CR163","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1083\/jcb.201111130","volume":"198","author":"N Schmidt","year":"2012","unstructured":"Schmidt N, Basu S, Sladecek S et al (2012) Agrin regulates CLASP2-mediated capture of microtubules at the neuromuscular junction synaptic membrane. J Cell Biol 198(3):421\u2013437. https:\/\/doi.org\/10.1083\/jcb.201111130","journal-title":"J Cell Biol"},{"key":"3821_CR164","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1126\/scisignal.2002829","volume":"5","author":"RJ Khairallah","year":"2012","unstructured":"Khairallah RJ, Shi G, Sbrana F et al (2012) Microtubules underlie dysfunction in duchenne muscular dystrophy. Sci Signal 5:56. https:\/\/doi.org\/10.1126\/scisignal.2002829","journal-title":"Sci Signal"},{"key":"3821_CR165","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/0304-3940(94)90154-6","volume":"173","author":"D Koltgen","year":"1994","unstructured":"Koltgen D, Franke C (1994) The coexistence of embryonic and adult acetylcholine receptors in sarcolemma of mdx dystrophic mouse muscle: an effect of regeneration or muscular dystrophy? Neurosci Lett 173:79\u201382. https:\/\/doi.org\/10.1016\/0304-3940(94)90154-6","journal-title":"Neurosci Lett"},{"issue":"1","key":"3821_CR166","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1152\/physrev.00043.2011","volume":"93","author":"H Yin","year":"2013","unstructured":"Yin H, Price F, Rudnicki MA (2013) Satellite cells and the muscle stem cell niche. Physiol Rev 93(1):23\u201367. https:\/\/doi.org\/10.1152\/physrev.00043.2011","journal-title":"Physiol Rev"},{"key":"3821_CR167","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.devcel.2018.06.018","volume":"46","author":"MN Wosczyna","year":"2018","unstructured":"Wosczyna MN, Rando TA (2018) A muscle stem cell support group: coordinated cellular responses in muscle regeneration. Dev Cell 46:135\u2013143. https:\/\/doi.org\/10.1016\/j.devcel.2018.06.018","journal-title":"Dev Cell"},{"key":"3821_CR168","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/nbt1334","volume":"25","author":"B Zheng","year":"2007","unstructured":"Zheng B, Cao B, Crisan M et al (2007) Prospective identification of myogenic endothelial cells in human skeletal muscle. Nat Biotechnol 25:1025\u20131034. https:\/\/doi.org\/10.1038\/nbt1334","journal-title":"Nat Biotechnol"},{"key":"3821_CR169","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1172\/JCI20325","volume":"114","author":"Y Torrente","year":"2004","unstructured":"Torrente Y, Belicchi M, Sampaolesi M et al (2004) Human circulating AC133+ stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle. J Clin Invest 114:182\u2013195. https:\/\/doi.org\/10.1172\/JCI20325","journal-title":"J Clin Invest"},{"key":"3821_CR170","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1038\/mt.2009.167","volume":"17","author":"E Negroni","year":"2009","unstructured":"Negroni E, Riederer I, Chaouch S et al (2009) In vivo myogenic potential of human CD133+ muscle-derived stem cells: a quantitative study. Mol Ther 17:1771\u20131778. https:\/\/doi.org\/10.1038\/mt.2009.167","journal-title":"Mol Ther"},{"key":"3821_CR171","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1242\/dev.089326","volume":"140","author":"A Pann\u00e9rec","year":"2013","unstructured":"Pann\u00e9rec A, Formicola L, Besson V et al (2013) Defining skeletal muscle resident progenitors and their cell fate potentials. Dev 140:2879\u20132891. https:\/\/doi.org\/10.1242\/dev.089326","journal-title":"Dev"},{"key":"3821_CR172","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1083\/jcb.200108150","volume":"157","author":"Z Qu-Petersen","year":"2002","unstructured":"Qu-Petersen Z, Deasy B, Jankowski R et al (2002) Identification of a novel population of muscle stem cells in mice: potential for muscle regeneration. J Cell Biol 157:851\u2013864. https:\/\/doi.org\/10.1083\/jcb.200108150","journal-title":"J Cell Biol"},{"key":"3821_CR173","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1002\/jor.24058","volume":"37","author":"J Huard","year":"2019","unstructured":"Huard J (2019) Stem cells, blood vessels, and angiogenesis as major determinants for musculoskeletal tissue repair. J Orthop Res 37:1212\u20131220. https:\/\/doi.org\/10.1002\/jor.24058","journal-title":"J Orthop Res"},{"key":"3821_CR174","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/ncb3477","volume":"19","author":"N Liu","year":"2017","unstructured":"Liu N, Garry GA, Li S et al (2017) A Twist2-dependent progenitor cell contributes to adult skeletal muscle. Nat Cell Biol 19:202\u2013213. https:\/\/doi.org\/10.1038\/ncb3477","journal-title":"Nat Cell Biol"},{"key":"3821_CR175","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1172\/JCI16157","volume":"111","author":"SM Majka","year":"2003","unstructured":"Majka SM, Jackson KA, Kienstra KA et al (2003) Distinct progenitor populations in skeletal muscle are bone marrow derived and exhibit different cell fates during vascular regeneration. J Clin Invest 111:71\u201379. https:\/\/doi.org\/10.1172\/JCI16157","journal-title":"J Clin Invest"},{"issue":"16","key":"3821_CR176","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1242\/dev.069088","volume":"139","author":"F Relaix","year":"2012","unstructured":"Relaix F, Zammit PS (2012) Satellite cells are essential for skeletal muscle regeneration: the cell on the edge returns centre stage. Development 139(16):2845\u20132856. https:\/\/doi.org\/10.1242\/dev.069088","journal-title":"Development"},{"key":"3821_CR177","doi-asserted-by":"publisher","first-page":"4536","DOI":"10.1242\/dev.084756","volume":"139","author":"P Mourikis","year":"2012","unstructured":"Mourikis P, Gopalakrishnan S, Sambasivan R, Tajbakhsh S (2012) Cell-autonomous notch activity maintains the temporal specification potential of skeletal muscle stem cells. Dev 139:4536\u20134548. https:\/\/doi.org\/10.1242\/dev.084756","journal-title":"Dev"},{"key":"3821_CR178","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.stem.2018.10.006","volume":"23","author":"P Feige","year":"2018","unstructured":"Feige P, Brun CE, Ritso M, Rudnicki MA (2018) Orienting muscle stem cells for regeneration in homeostasis, aging, and disease. Cell Stem Cell 23:653\u2013664. https:\/\/doi.org\/10.1016\/j.stem.2018.10.006","journal-title":"Cell Stem Cell"},{"key":"3821_CR179","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1242\/dev.114223","volume":"142","author":"NA Dumont","year":"2015","unstructured":"Dumont NA, Wang YX, Rudnicki MA (2015) Intrinsic and extrinsic mechanisms regulating satellite cell function. Dev 142:1572\u20131581. https:\/\/doi.org\/10.1242\/dev.114223","journal-title":"Dev"},{"key":"3821_CR180","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.cell.2007.03.044","volume":"129","author":"S Kuang","year":"2007","unstructured":"Kuang S, Kuroda K, Le GF, Rudnicki MA (2007) Asymmetric self-renewal and commitment of satellite stem cells in muscle. Cell 129:999\u20131010. https:\/\/doi.org\/10.1016\/j.cell.2007.03.044","journal-title":"Cell"},{"issue":"3","key":"3821_CR181","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1002\/cphy.c140068","volume":"5","author":"NA Dumont","year":"2015","unstructured":"Dumont NA, Bentzinger CF, Sincennes MC, Rudnicki MA (2015) Satellite cells and skeletal muscle regeneration. Compr Physiol 5(3):1027\u20131059. https:\/\/doi.org\/10.1002\/cphy.c140068","journal-title":"Compr Physiol"},{"key":"3821_CR182","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1242\/dev.122317","volume":"142","author":"R Ogawa","year":"2015","unstructured":"Ogawa R, Ma Y, Yamaguchi M et al (2015) Doublecortin marks a new population of transiently amplifying muscle progenitor cells and is required for myofiber maturation during skeletal muscle regeneration. Dev 142:810. https:\/\/doi.org\/10.1242\/dev.122317","journal-title":"Dev"},{"key":"3821_CR183","doi-asserted-by":"publisher","first-page":"24","DOI":"10.2174\/1389202920666190116094736","volume":"20","author":"L Forcina","year":"2019","unstructured":"Forcina L, Miano C, Pelosi L, Musar\u00f2 A (2019) An overview about the muscle satellite cells biology of skeletal . Curr Genomics 20:24\u201337. https:\/\/doi.org\/10.2174\/1389202920666190116094736","journal-title":"Curr Genomics"},{"key":"3821_CR184","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1038\/nm.3990","volume":"21","author":"NA Dumont","year":"2015","unstructured":"Dumont NA, Wang YX, Von MJ et al (2015) Dystrophin expression in muscle stem cells regulates their polarity and asymmetric division. Nat Med 21:1455\u20131463. https:\/\/doi.org\/10.1038\/nm.3990","journal-title":"Nat Med"},{"issue":"3","key":"3821_CR185","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.stem.2012.07.001","volume":"11","author":"Y Kawabe","year":"2012","unstructured":"Kawabe Y, Wang YX, McKinnell IW, Bedford MT, Rudnicki MA (2012) Carm1 regulates Pax7 transcriptional activity through MLL1\/2 recruitment during asymmetric satellite stem cell divisions. Cell Stem Cell 11(3):333\u2013345. https:\/\/doi.org\/10.1016\/j.stem.2012.07.001","journal-title":"Cell Stem Cell"},{"key":"3821_CR186","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nature18014","volume":"534","author":"HJR Shin","year":"2016","unstructured":"Shin HJR, Kim H, Oh S et al (2016) AMPK-SKP2-CARM1 signalling cascade in transcriptional regulation of autophagy. Nature 534:553\u2013557. https:\/\/doi.org\/10.1038\/nature18014","journal-title":"Nature"},{"key":"3821_CR187","doi-asserted-by":"publisher","first-page":"e1363","DOI":"10.1038\/cddis.2014.312","volume":"5","author":"C De Palma","year":"2014","unstructured":"De Palma C, Morisi F, Cheli S et al (2014) Autophagy as a new therapeutic target in Duchenne muscular dystrophy. Cell Death Dis 5:e1363. https:\/\/doi.org\/10.1038\/cddis.2014.312","journal-title":"Cell Death Dis"},{"key":"3821_CR188","doi-asserted-by":"publisher","first-page":"ecurrents.md.e1","DOI":"10.1371\/currents.md.e1226cefa851a2f079bbc406c0a21e80","volume":"5","author":"P Spitali","year":"2013","unstructured":"Spitali P, Grumati P, Hiller M, Chrisam M, Aartsma-Rus A, Bonaldo P (2013) Autophagy is impaired in the tibialis anterior of dystrophin null mice. PLoS Curr 5:ecurrents.md.e1226cefa851a2f079bbc406c0a21e80. https:\/\/doi.org\/10.1371\/currents.md.e1226cefa851a2f079bbc406c0a21e80","journal-title":"PLoS Curr"},{"key":"3821_CR189","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nature16187","volume":"529","author":"L Garc\u00eda-Prat","year":"2016","unstructured":"Garc\u00eda-Prat L, Mart\u00ednez-Vicente M, Perdiguero E et al (2016) Autophagy maintains stemness by preventing senescence. Nature 529:37\u201342. https:\/\/doi.org\/10.1038\/nature16187","journal-title":"Nature"},{"key":"3821_CR190","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s00441-010-0976-6","volume":"340","author":"M Kottlors","year":"2010","unstructured":"Kottlors M, Kirschner J (2010) Elevated satellite cell number in Duchenne muscular dystrophy. Cell Tissue Res 340:541\u2013548. https:\/\/doi.org\/10.1007\/s00441-010-0976-6","journal-title":"Cell Tissue Res"},{"key":"3821_CR191","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1111\/his.12231","volume":"63","author":"LC Bankol\u00e9","year":"2013","unstructured":"Bankol\u00e9 LC, Feasson L, Ponsot E, Kadi F (2013) Fibre type-specific satellite cell content in two models of muscle disease. Histopathology 63:826\u2013832. https:\/\/doi.org\/10.1111\/his.12231","journal-title":"Histopathology"},{"key":"3821_CR192","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1038\/nm.4006","volume":"21","author":"AC Keefe","year":"2015","unstructured":"Keefe AC, Kardon G (2015) A new role for dystrophin in muscle stem cells. Nat Med 21:1391\u20131393. https:\/\/doi.org\/10.1038\/nm.4006","journal-title":"Nat Med"},{"key":"3821_CR193","doi-asserted-by":"publisher","first-page":"4786","DOI":"10.1093\/hmg\/ddu194","volume":"23","author":"A Lu","year":"2014","unstructured":"Lu A, Poddar M, Tang Y et al (2014) Rapid depletion of muscle progenitor cells in dystrophic mdx\/utrophin-\/- mice. Hum Mol Genet 23:4786\u20134800. https:\/\/doi.org\/10.1093\/hmg\/ddu194","journal-title":"Hum Mol Genet"},{"key":"3821_CR194","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1089\/ars.2017.7435","volume":"29","author":"K Pietraszek-Gremplewicz","year":"2018","unstructured":"Pietraszek-Gremplewicz K, Kozakowska M, Bronisz-Budzynska I et al (2018) Heme oxygenase-1 influences satellite cells and progression of duchenne muscular dystrophy in mice. Antioxid Redox Signal 29:128\u2013148. https:\/\/doi.org\/10.1089\/ars.2017.7435","journal-title":"Antioxid Redox Signal"},{"issue":"2","key":"3821_CR195","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1089\/ars.2011.3964","volume":"16","author":"M Kozakowska","year":"2012","unstructured":"Kozakowska M, Ciesla M, Stefanska A et al (2012) Heme oxygenase-1 inhibits myoblast differentiation by targeting myomirs. Antioxid Redox Signal 16(2):113\u2013127. https:\/\/doi.org\/10.1089\/ars.2011.3964","journal-title":"Antioxid Redox Signal"},{"issue":"38","key":"3821_CR196","doi-asserted-by":"publisher","first-page":"E5246","DOI":"10.1073\/pnas.1512869112","volume":"112","author":"SA Dick","year":"2015","unstructured":"Dick SA, Chang NC, Dumont NA et al (2015) Caspase 3 cleavage of Pax7 inhibits self-renewal of satellite cells. Proc Natl Acad Sci USA 112(38):E5246\u2013E5252. https:\/\/doi.org\/10.1073\/pnas.1512869112","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"3821_CR197","doi-asserted-by":"publisher","first-page":"842","DOI":"10.4161\/epi.28597","volume":"9","author":"J Terragni","year":"2014","unstructured":"Terragni J, Zhang G, Sun Z, Pradhan S, Song L, Crawford GE, Lacey M, Ehrlich M (2014) Notch signaling genes: myogenic DNA hypomethylation and 5-hydroxymethylcytosine. Epigenetics 9(6):842\u2013850. https:\/\/doi.org\/10.4161\/epi.28597","journal-title":"Epigenetics"},{"issue":"1","key":"3821_CR198","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/dgd.12626","volume":"62","author":"R Sueda","year":"2020","unstructured":"Sueda R, Kageyama R (2020) Regulation of active and quiescent somatic stem cells by Notch signaling. Dev Growth Differ 62(1):59\u201366. https:\/\/doi.org\/10.1111\/dgd.12626","journal-title":"Dev Growth Differ"},{"key":"3821_CR199","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1093\/hmg\/ddv055","volume":"24","author":"X Mu","year":"2015","unstructured":"Mu X, Tang Y, Lu A et al (2015) The role of Notch signaling in muscle progenitor cell depletion and the rapid onset of histopathology in muscular dystrophy. Hum Mol Genet 24:2923\u20132937. https:\/\/doi.org\/10.1093\/hmg\/ddv055","journal-title":"Hum Mol Genet"},{"key":"3821_CR200","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.nmd.2009.10.011","volume":"20","author":"E Zucconi","year":"2010","unstructured":"Zucconi E, Valadares MC, Vieira NM et al (2010) Ringo: discordance between the molecular and clinical manifestation in a golden retriever muscular Dystrophy dog. Neuromuscul Disord 20:64\u201370. https:\/\/doi.org\/10.1016\/j.nmd.2009.10.011","journal-title":"Neuromuscul Disord"},{"key":"3821_CR201","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/j.cell.2015.10.049","volume":"163","author":"NM Vieira","year":"2015","unstructured":"Vieira NM, Elvers I, Alexander MS et al (2015) Jagged 1 rescues the Duchenne muscular dystrophy phenotype. Cell 163:1204\u20131213. https:\/\/doi.org\/10.1016\/j.cell.2015.10.049","journal-title":"Cell"},{"issue":"5","key":"3821_CR202","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1161\/ATVBAHA.114.304741","volume":"35","author":"AR Pedrosa","year":"2015","unstructured":"Pedrosa AR, Trindade A, Fernandes AC et al (2015) Endothelial Jagged1 antagonizes Dll4 regulation of endothelial branching and promotes vascular maturation downstream of Dll4\/Notch1. Arterioscler Thromb Vasc Biol 35(5):1134\u20131146. https:\/\/doi.org\/10.1161\/ATVBAHA.114.304741","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"12","key":"3821_CR203","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.5966\/sctm.2014-0034","volume":"3","author":"Y Dong","year":"2014","unstructured":"Dong Y, Long T, Wang C, Mirando AJ, Chen J, O\u2019Keefe RJ, Hilton MJ (2014) NOTCH-mediated maintenance and expansion of human bone marrow stromal\/stem cells: a technology designed for orthopedic regenerative medicine. Stem Cells Transl Med 3(12):1456\u20131466. https:\/\/doi.org\/10.5966\/sctm.2014-0034","journal-title":"Stem Cells Transl Med"},{"key":"3821_CR204","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.stem.2019.01.002","volume":"24","author":"YX Wang","year":"2019","unstructured":"Wang YX, Feige P, Brun CE et al (2019) EGFR-aurka signaling rescues polarity and regeneration defects in dystrophin-deficient muscle stem cells by increasing asymmetric divisions. Cell Stem Cell 24:419\u2013432. https:\/\/doi.org\/10.1016\/j.stem.2019.01.002","journal-title":"Cell Stem Cell"},{"key":"3821_CR205","doi-asserted-by":"publisher","first-page":"20614","DOI":"10.1073\/pnas.1215765109","volume":"109","author":"J von Maltzahn","year":"2012","unstructured":"von Maltzahn J, Renaud JM, Parise G, Rudnicki MA (2012) Wnt7a treatment ameliorates muscular dystrophy. Proc Natl Acad Sci USA 109:20614\u201320619. https:\/\/doi.org\/10.1073\/pnas.1215765109","journal-title":"Proc Natl Acad Sci USA"},{"key":"3821_CR206","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.stem.2009.03.013","volume":"4","author":"F Le Grand","year":"2009","unstructured":"Le Grand F, Jones AE, Seale V et al (2009) Wnt7a activates the planar cell polarity pathway to drive the symmetric expansion of satellite stem cells. Cell Stem Cell 4:535\u2013547. https:\/\/doi.org\/10.1016\/j.stem.2009.03.013","journal-title":"Cell Stem Cell"},{"key":"3821_CR207","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1126\/scitranslmed.3008411","volume":"6","author":"S Biressi","year":"2014","unstructured":"Biressi S, Miyabara EH, Gopinath SD et al (2014) A Wnt-TGF\u03b22 axis induces a fibrogenic program in muscle stem cells from dystrophic mice. Sci Transl Med 6:267. https:\/\/doi.org\/10.1126\/scitranslmed.3008411","journal-title":"Sci Transl Med"},{"key":"3821_CR208","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.scr.2014.10.007","volume":"14","author":"L Boldrin","year":"2015","unstructured":"Boldrin L, Zammit PS, Morgan JE (2015) Satellite cells from dystrophic muscle retain regenerative capacity. Stem Cell Res 14:20\u201329. https:\/\/doi.org\/10.1016\/j.scr.2014.10.007","journal-title":"Stem Cell Res"},{"issue":"10","key":"3821_CR209","doi-asserted-by":"publisher","first-page":"e006340","DOI":"10.1161\/JAHA.117.006340","volume":"6","author":"D Cheeran","year":"2017","unstructured":"Cheeran D, Khan S, Khera R et al (2017) Predictors of death in adults with duchenne muscular dystrophy-associated cardiomyopathy. J Am Heart Assoc 6(10):e006340. https:\/\/doi.org\/10.1161\/JAHA.117.006340","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"3821_CR210","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/ppul.23215","volume":"51","author":"DJ Birnkrant","year":"2016","unstructured":"Birnkrant DJ, Ararat E, Mhanna MJ (2016) Cardiac phenotype determines survival in Duchenne muscular dystrophy. Pediatr Pulmonol 51(1):70\u201376. https:\/\/doi.org\/10.1002\/ppul.23215","journal-title":"Pediatr Pulmonol"},{"issue":"21","key":"3821_CR211","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1016\/j.jacc.2016.02.081","volume":"67","author":"F Kamdar","year":"2016","unstructured":"Kamdar F, Garry DJ (2016) Dystrophin-deficient cardiomyopathy. J Am Coll Cardiol 67(21):2533\u20132546. https:\/\/doi.org\/10.1016\/j.jacc.2016.02.081","journal-title":"J Am Coll Cardiol"},{"key":"3821_CR212","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.semcdb.2019.09.003","volume":"100","author":"A Vujic","year":"2020","unstructured":"Vujic A, Natarajan N, Lee RT (2020) Molecular mechanisms of heart regeneration. Semin Cell Dev Biol 100:20\u201328. https:\/\/doi.org\/10.1016\/j.semcdb.2019.09.003","journal-title":"Semin Cell Dev Biol"},{"issue":"11","key":"3821_CR213","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1253\/circj.CJ-16-1003","volume":"80","author":"MJ Ivey","year":"2016","unstructured":"Ivey MJ, Tallquist MD (2016) Defining the cardiac fibroblast. Circ J 80(11):2269\u20132276. https:\/\/doi.org\/10.1253\/circj.CJ-16-1003","journal-title":"Circ J"},{"key":"3821_CR214","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-2377-10-33","volume":"10","author":"S Mavrogeni","year":"2010","unstructured":"Mavrogeni S, Papavasiliou A, Spargias K et al (2010) Myocardial inflammation in duchenne muscular dystrophy as a precipitating factor for heart failure: a prospective study. BMC Neurol 10:33. https:\/\/doi.org\/10.1186\/1471-2377-10-33","journal-title":"BMC Neurol"},{"key":"3821_CR215","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.yjmcc.2013.07.014","volume":"63","author":"N Ieronimakis","year":"2013","unstructured":"Ieronimakis N, Hays AL, Janebodin K et al (2013) Coronary adventitial cells are linked to perivascular cardiac fibrosis via TGF\u03b21 signaling in the mdx mouse model of Duchenne muscular dystrophy. J Mol Cell Cardiol 63:122\u2013134. https:\/\/doi.org\/10.1016\/j.yjmcc.2013.07.014","journal-title":"J Mol Cell Cardiol"},{"issue":"2","key":"3821_CR216","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.ajpath.2018.10.010","volume":"189","author":"A Farini","year":"2019","unstructured":"Farini A, Gowran A, Bella P et al (2019) Fibrosis rescue improves cardiac function in dystrophin-deficient mice and duchenne patient-specific cardiomyocytes by immunoproteasome modulation. Am J Pathol 189(2):339\u2013353. https:\/\/doi.org\/10.1016\/j.ajpath.2018.10.010","journal-title":"Am J Pathol"},{"issue":"1","key":"3821_CR217","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1042\/BJ20120787","volume":"449","author":"J Ramachandran","year":"2013","unstructured":"Ramachandran J, Schneider JS, Crassous PA, Zheng R, Gonzalez JP, Xie LH, Beuve A, Fraidenraich D, Peluffo RD (2013) Nitric oxide signalling pathway in Duchenne muscular dystrophy mice: up-regulation of L-arginine transporters. Biochem J 449(1):133\u2013142. https:\/\/doi.org\/10.1042\/BJ20120787","journal-title":"Biochem J"},{"issue":"1","key":"3821_CR218","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1152\/physrev.00007.2015","volume":"96","author":"DG Allen","year":"2016","unstructured":"Allen DG, Whitehead NP, Froehner SC (2016) Absence of dystrophin disrupts skeletal muscle signaling: roles of Ca2+, reactive oxygen species, and nitric oxide in the development of muscular dystrophy. Physiol Rev 96(1):253\u2013305. https:\/\/doi.org\/10.1152\/physrev.00007.2015","journal-title":"Physiol Rev"},{"issue":"19","key":"3821_CR219","doi-asserted-by":"publisher","first-page":"7056","DOI":"10.3390\/ijms21197056","volume":"21","author":"M Brescia","year":"2020","unstructured":"Brescia M, Chao YC, Koschinski A, Tomek J, Zaccolo M (2020) Multi-compartment, early disruption of cGMP and cAMP signalling in cardiac myocytes from the mdx model of duchenne muscular dystrophy. Int J Mol Sci 21(19):7056. https:\/\/doi.org\/10.3390\/ijms21197056","journal-title":"Int J Mol Sci"},{"issue":"2","key":"3821_CR220","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3390\/jcm9020520","volume":"9","author":"ML Law","year":"2020","unstructured":"Law ML, Cohen H, Martin AA, Angulski ABB, Metzger JM (2020) Dysregulation of calcium handling in duchenne muscular dystrophy-associated dilated cardiomyopathy: mechanisms and experimental therapeutic strategies. J Clin Med 9(2):520. https:\/\/doi.org\/10.3390\/jcm9020520","journal-title":"J Clin Med"},{"issue":"2","key":"3821_CR221","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.ceca.2015.04.006","volume":"58","author":"V Kyrychenko","year":"2015","unstructured":"Kyrychenko V, Pol\u00e1kov\u00e1 E, Jan\u00ed\u010dek R, Shirokova N (2015) Mitochondrial dysfunctions during progression of dystrophic cardiomyopathy. Cell Calcium 58(2):186\u2013195. https:\/\/doi.org\/10.1016\/j.ceca.2015.04.006","journal-title":"Cell Calcium"},{"issue":"1","key":"3821_CR222","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1093\/cvr\/cvx201","volume":"114","author":"C Kang","year":"2018","unstructured":"Kang C, Badr MA, Kyrychenko V, Eskelinen EL, Shirokova N (2018) Deficit in PINK1\/PARKIN-mediated mitochondrial autophagy at late stages of dystrophic cardiomyopathy. Cardiovasc Res 114(1):90\u2013102. https:\/\/doi.org\/10.1093\/cvr\/cvx201","journal-title":"Cardiovasc Res"},{"issue":"11","key":"3821_CR223","doi-asserted-by":"publisher","first-page":"dmm45559","DOI":"10.1242\/dmm.045559","volume":"13","author":"M Gartz","year":"2020","unstructured":"Gartz M, Lin CW, Sussman MA, Lawlor MW, Strande JL (2020) Duchenne muscular dystrophy (DMD) cardiomyocyte-secreted exosomes promote the pathogenesis of DMD-associated cardiomyopathy. Dis Model Mech 13(11):dmm45559. https:\/\/doi.org\/10.1242\/dmm.045559","journal-title":"Dis Model Mech"},{"issue":"17","key":"3821_CR224","doi-asserted-by":"publisher","first-page":"4098","DOI":"10.3390\/ijms20174098","volume":"20","author":"TA Meyers","year":"2019","unstructured":"Meyers TA, Townsend D (2019) Cardiac pathophysiology and the future of cardiac therapies in duchenne muscular dystrophy. Int J Mol Sci 20(17):4098. https:\/\/doi.org\/10.3390\/ijms20174098","journal-title":"Int J Mol Sci"},{"issue":"6","key":"3821_CR225","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1161\/01.cir.103.6.864","volume":"103","author":"L Loufrani","year":"2001","unstructured":"Loufrani L, Matrougui K, Gorny D, Duriez M, Blanc I, L\u00e9vy BI, Henrion D (2001) Flow (shear stress)-induced endothelium-dependent dilation is altered in mice lacking the gene encoding for dystrophin. Circulation 103(6):864\u2013870. https:\/\/doi.org\/10.1161\/01.cir.103.6.864","journal-title":"Circulation"},{"issue":"1","key":"3821_CR226","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/2044-5040-3-14","volume":"3","author":"M Raith","year":"2013","unstructured":"Raith M, Valencia RG, Fischer I, Orthofer M, Penninger JM, Spuler S, Rezniczek GA, Wiche G (2013) Linking cytoarchitecture to metabolism: sarcolemma-associated plectin affects glucose uptake by destabilizing microtubule networks in mdx myofibers. Skelet Muscle 3(1):14. https:\/\/doi.org\/10.1186\/2044-5040-3-14","journal-title":"Skelet Muscle"},{"issue":"1","key":"3821_CR227","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/proteomes9010009","volume":"9","author":"P Dowling","year":"2021","unstructured":"Dowling P, Gargan S, Murphy S, Zweyer M, Sabir H, Swandulla D, Ohlendieck K (2021) The dystrophin node as integrator of cytoskeletal organization, lateral force transmission, fiber stability and cellular signaling in skeletal muscle. Proteomes 9(1):9. https:\/\/doi.org\/10.3390\/proteomes9010009","journal-title":"Proteomes"},{"issue":"12","key":"3821_CR228","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1002\/mus.1192","volume":"24","author":"TA Rando","year":"2001","unstructured":"Rando TA (2001) The dystrophin-glycoprotein complex, cellular signaling, and the regulation of cell survival in the muscular dystrophies. Muscle Nerve 24(12):1575\u20131594. https:\/\/doi.org\/10.1002\/mus.1192","journal-title":"Muscle Nerve"},{"issue":"3","key":"3821_CR229","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1172\/JCI36612","volume":"119","author":"Y Lai","year":"2009","unstructured":"Lai Y, Thomas GD, Yue Y et al (2009) Dystrophins carrying spectrin-like repeats 16 and 17 anchor nNOS to the sarcolemma and enhance exercise performance in a mouse model of muscular dystrophy. J Clin Invest 119(3):624\u2013635. https:\/\/doi.org\/10.1172\/JCI36612","journal-title":"J Clin Invest"},{"issue":"23","key":"3821_CR230","doi-asserted-by":"publisher","first-page":"5183","DOI":"10.1113\/JP271252","volume":"593","author":"MD Nelson","year":"2015","unstructured":"Nelson MD, Rosenberry R, Barresi R et al (2015) Sodium nitrate alleviates functional muscle ischaemia in patients with Becker muscular dystrophy. J Physiol 593(23):5183\u20135200. https:\/\/doi.org\/10.1113\/JP271252","journal-title":"J Physiol"},{"issue":"1","key":"3821_CR231","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s13023-017-0652-y","volume":"12","author":"CA Timpani","year":"2017","unstructured":"Timpani CA, Hayes A, Rybalka E (2017) Therapeutic strategies to address neuronal nitric oxide synthase deficiency and the loss of nitric oxide bioavailability in Duchenne Muscular Dystrophy. Orphanet J Rare Dis 12(1):100. https:\/\/doi.org\/10.1186\/s13023-017-0652-y","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"3821_CR232","doi-asserted-by":"publisher","first-page":"151","DOI":"10.11005\/jbm.2020.27.3.151","volume":"27","author":"J Suh","year":"2020","unstructured":"Suh J, Lee YS (2020) Myostatin Inhibitors: panacea or predicament for musculoskeletal disorders? J Bone Metab 27(3):151\u2013165. https:\/\/doi.org\/10.11005\/jbm.2020.27.3.151","journal-title":"J Bone Metab"},{"issue":"5","key":"3821_CR233","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1097\/WCO.0000000000000853","volume":"33","author":"KR Wagner","year":"2020","unstructured":"Wagner KR (2020) The elusive promise of myostatin inhibition for muscular dystrophy. Curr Opin Neurol 33(5):621\u2013628. https:\/\/doi.org\/10.1097\/WCO.0000000000000853","journal-title":"Curr Opin Neurol"},{"issue":"4","key":"3821_CR234","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.3892\/etm.2017.4105","volume":"13","author":"Y Song","year":"2017","unstructured":"Song Y, Yao S, Liu Y et al (2017) Expression levels of TGF-\u03b21 and CTGF are associated with the severity of Duchenne muscular dystrophy. Exp Ther Med 13(4):1209\u20131214. https:\/\/doi.org\/10.3892\/etm.2017.4105","journal-title":"Exp Ther Med"},{"key":"3821_CR235","doi-asserted-by":"publisher","first-page":"593269","DOI":"10.3389\/fcell.2020.593269","volume":"8","author":"Z Chen","year":"2020","unstructured":"Chen Z, Zhang N, Chu HY, Yu Y, Zhang ZK, Zhang G, Zhang BT (2020) Connective tissue growth factor: from molecular understandings to drug discovery. Front Cell Dev Biol 8:593269. https:\/\/doi.org\/10.3389\/fcell.2020.593269","journal-title":"Front Cell Dev Biol"},{"key":"3821_CR236","doi-asserted-by":"publisher","first-page":"16006","DOI":"10.1038\/npjregenmed.2016.6","volume":"1","author":"NA Dumont","year":"2016","unstructured":"Dumont NA, Rudnicki MA (2016) Targeting muscle stem cell intrinsic defects to treat Duchenne muscular dystrophy. NPJ Regen Med 1:16006. https:\/\/doi.org\/10.1038\/npjregenmed.2016.6","journal-title":"NPJ Regen Med"},{"issue":"1","key":"3821_CR237","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3233\/JND-180341","volume":"6","author":"E Finanger","year":"2019","unstructured":"Finanger E, Vandenborne K, Finkel RS et al (2019) Phase 1 study of edasalonexent (CAT-1004), an Oral NF-\u03baB inhibitor, in pediatric patients with duchenne muscular dystrophy. J Neuromuscul Dis 6(1):43\u201354. https:\/\/doi.org\/10.3233\/JND-180341","journal-title":"J Neuromuscul Dis"},{"key":"3821_CR238","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.phrs.2018.09.007","volume":"136","author":"LS Conklin","year":"2018","unstructured":"Conklin LS, Damsker JM, Hoffman EP et al (2018) Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first-in-class dissociative steroidal anti-inflammatory drug. Pharmacol Res 136:140\u2013150. https:\/\/doi.org\/10.1016\/j.phrs.2018.09.007","journal-title":"Pharmacol Res"},{"issue":"5","key":"3821_CR239","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1002\/jcph.842","volume":"57","author":"JM Donovan","year":"2017","unstructured":"Donovan JM, Zimmer M, Offman E, Grant T, Jirousek M (2017) A novel NF-\u03baB inhibitor, edasalonexent (CAT-1004), in development as a disease-modifying treatment for patients with duchenne muscular dystrophy: phase 1 safety, pharmacokinetics, and pharmacodynamics in adult subjects. J Clin Pharmacol 57(5):627\u2013639. https:\/\/doi.org\/10.1002\/jcph.842","journal-title":"J Clin Pharmacol"},{"issue":"1","key":"3821_CR240","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13395-019-0207-0","volume":"9","author":"I Bronisz-Budzy\u0144ska","year":"2019","unstructured":"Bronisz-Budzy\u0144ska I, Chwalenia K, Mucha O, Podkalicka P, Karolina-Bukowska-Strakova JA, \u0141oboda A, Kozakowska M, Dulak J (2019) miR-146a deficiency does not aggravate muscular dystrophy in mdx mice. Skelet Muscle 9(1):22. https:\/\/doi.org\/10.1186\/s13395-019-0207-0","journal-title":"Skelet Muscle"},{"issue":"18","key":"3821_CR241","doi-asserted-by":"publisher","first-page":"4638","DOI":"10.3390\/ijms20184638","volume":"20","author":"HC Hrach","year":"2019","unstructured":"Hrach HC, Mangone M (2019) miRNA profiling for early detection and treatment of duchenne muscular dystrophy. Int J Mol Sci 20(18):4638. https:\/\/doi.org\/10.3390\/ijms20184638","journal-title":"Int J Mol Sci"},{"issue":"11","key":"3821_CR242","doi-asserted-by":"publisher","first-page":"e135576","DOI":"10.1172\/jci.insight.135576","volume":"5","author":"P Podkalicka","year":"2020","unstructured":"Podkalicka P, Mucha O, Bronisz-Budzy\u0144ska I, Kozakowska M et al (2020) Lack of miR-378 attenuates muscular dystrophy in mdx mice. JCI Insight 5(11):e135576. https:\/\/doi.org\/10.1172\/jci.insight.135576","journal-title":"JCI Insight"},{"issue":"16","key":"3821_CR243","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1093\/hmg\/ddn151","volume":"17","author":"E Kimura","year":"2008","unstructured":"Kimura E, Han JJ, Li S, Fall B, Ra J, Haraguchi M, Tapscott SJ, Chamberlain JS (2008) Cell-lineage regulated myogenesis for dystrophin replacement: a novel therapeutic approach for treatment of muscular dystrophy. Hum Mol Genet 17(16):2507\u20132517. https:\/\/doi.org\/10.1093\/hmg\/ddn151","journal-title":"Hum Mol Genet"},{"key":"3821_CR244","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/35100529","volume":"1","author":"R Medzhitov","year":"2001","unstructured":"Medzhitov R (2001) Toll-like receptors and innate immunity. Nat Rev Immunol 1:135\u2013145. https:\/\/doi.org\/10.1038\/35100529","journal-title":"Nat Rev Immunol"},{"key":"3821_CR245","doi-asserted-by":"publisher","first-page":"1","DOI":"10.12703\/P6-97","volume":"7","author":"J Deguine","year":"2014","unstructured":"Deguine J, Barton GM (2014) MyD88: a central player in innate immune signaling. F1000Prime Rep 7:1\u20137. https:\/\/doi.org\/10.12703\/P6-97","journal-title":"F1000Prime Rep"},{"key":"3821_CR246","doi-asserted-by":"publisher","first-page":"17023","DOI":"10.1038\/sigtrans.2017.23","volume":"2","author":"T Liu","year":"2017","unstructured":"Liu T, Zhang L, Joo D, Sun SC (2017) NF-\u03baB signaling in inflammation. Signal Transduct Target Ther 2:17023. https:\/\/doi.org\/10.1038\/sigtrans.2017.23","journal-title":"Signal Transduct Target Ther"},{"key":"3821_CR247","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cell.2016.12.012","volume":"168","author":"Q Zhang","year":"2017","unstructured":"Zhang Q, Lenardo MJ, Baltimore D (2017) 30 Years of NF-\u03baB: a blossoming of relevance to human pathobiology. Cell 168:37\u201357. https:\/\/doi.org\/10.1016\/j.cell.2016.12.012","journal-title":"Cell"},{"key":"3821_CR248","doi-asserted-by":"publisher","first-page":"E131","DOI":"10.1038\/ncb0502-e131","volume":"4","author":"E Shaulian","year":"2002","unstructured":"Shaulian E, Karin M (2002) AP-1 as a regulator of cell life and death. Nat Cell Biol 4:E131-136. https:\/\/doi.org\/10.1038\/ncb0502-e131","journal-title":"Nat Cell Biol"},{"key":"3821_CR249","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.pmbts.2017.02.005","volume":"147","author":"N Cui","year":"2017","unstructured":"Cui N, Hu M, Khalil RA (2017) Biochemical and biological attributes of matrix metalloproteinases. Prog Mol Biol Transl Sci 147:1\u201373. https:\/\/doi.org\/10.1016\/bs.pmbts.2017.02.005","journal-title":"Prog Mol Biol Transl Sci"},{"key":"3821_CR250","doi-asserted-by":"publisher","first-page":"111","DOI":"10.12688\/f1000research.17023.1","volume":"8","author":"J Holbrook","year":"2019","unstructured":"Holbrook J, Lara-Reyna S, Jarosz-Griffiths H, McDermott MF (2019) Tumour necrosis factor signalling in health and disease. F1000Research 8:111. https:\/\/doi.org\/10.12688\/f1000research.17023.1","journal-title":"F1000Research"},{"key":"3821_CR251","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41581-018-0078-3","volume":"15","author":"M Kuro-o","year":"2019","unstructured":"Kuro-o M (2019) The Klotho proteins in health and disease. Nat Rev Nephrol 15:27\u201344. https:\/\/doi.org\/10.1038\/s41581-018-0078-3","journal-title":"Nat Rev Nephrol"},{"key":"3821_CR252","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1038\/nrm3434","volume":"13","author":"J Massagu\u00e9","year":"2012","unstructured":"Massagu\u00e9 J (2012) TGF\u03b2 signalling in context. Nat Rev Mol Cell Biol 13:616\u2013630. https:\/\/doi.org\/10.1038\/nrm3434","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3821_CR253","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1479-7364-5-1-30","volume":"5","author":"C Brocker","year":"2010","unstructured":"Brocker C, Thompson D, Matsumoto A et al (2010) Evolutionary divergence and functions of the human interleukin (IL) gene family. Hum Genomics 5:30\u201355. https:\/\/doi.org\/10.1186\/1479-7364-5-1-30","journal-title":"Hum Genomics"},{"key":"3821_CR254","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.clinbiochem.2018.07.003","volume":"59","author":"MA Icer","year":"2018","unstructured":"Icer MA, Gezmen-Karadag M (2018) The multiple functions and mechanisms of osteopontin. Clin Biochem 59:17\u201324. https:\/\/doi.org\/10.1016\/j.clinbiochem.2018.07.003","journal-title":"Clin Biochem"},{"key":"3821_CR255","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41232-019-0111-3","volume":"40","author":"T Ono","year":"2020","unstructured":"Ono T, Hayashi M, Sasaki F, Nakashima T (2020) RANKL biology: bone metabolism, the immune system, and beyond. Inflamm Regen 40:1\u201316. https:\/\/doi.org\/10.1186\/s41232-019-0111-3","journal-title":"Inflamm Regen"},{"key":"3821_CR256","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/ni.3153","volume":"16","author":"CA Hunter","year":"2015","unstructured":"Hunter CA, Jones SA (2015) IL-6 as a keystone cytokine in health and disease. Nat Immunol 16:448\u2013457. https:\/\/doi.org\/10.1038\/ni.3153","journal-title":"Nat Immunol"},{"key":"3821_CR257","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.cytogfr.2015.07.001","volume":"26","author":"NA Nicola","year":"2015","unstructured":"Nicola NA, Babon JJ (2015) Leukemia inhibitory factor (LIF). Cytokine Growth Factor Rev 26:533\u2013544. https:\/\/doi.org\/10.1016\/j.cytogfr.2015.07.001","journal-title":"Cytokine Growth Factor Rev"},{"key":"3821_CR258","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.mce.2015.12.014","volume":"432","author":"N Bonnet","year":"2016","unstructured":"Bonnet N, Garnero P, Ferrari S (2016) Periostin action in bone. Mol Cell Endocrinol 432:75\u201382. https:\/\/doi.org\/10.1016\/j.mce.2015.12.014","journal-title":"Mol Cell Endocrinol"},{"key":"3821_CR259","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphys.2019.00419","volume":"10","author":"C Tezze","year":"2019","unstructured":"Tezze C, Romanello V, Sandri M (2019) FGF21 as modulator of metabolism in health and disease. Front Physiol 10:1\u20139. https:\/\/doi.org\/10.3389\/fphys.2019.00419","journal-title":"Front Physiol"},{"key":"3821_CR260","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.niox.2018.11.004","volume":"82","author":"JE Balke","year":"2019","unstructured":"Balke JE, Zhang L, Percival JM (2019) Neuronal nitric oxide synthase (nNOS) splice variant function: Insights into nitric oxide signaling from skeletal muscle. Nitric Oxide 82:35\u201347. https:\/\/doi.org\/10.1016\/j.niox.2018.11.004","journal-title":"Nitric Oxide"},{"issue":"2","key":"3821_CR261","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1042\/BJ20110301","volume":"437","author":"S Koch","year":"2011","unstructured":"Koch S, Tugues S, Li X, Gualandi L, Claesson-Welsh L (2011) Signal transduction by vascular endothelial growth factor receptors. Biochem J 437(2):169\u2013183. https:\/\/doi.org\/10.1042\/BJ20110301","journal-title":"Biochem J"},{"key":"3821_CR262","doi-asserted-by":"publisher","first-page":"345","DOI":"10.7150\/ijbs.10921","volume":"11","author":"G Ma","year":"2015","unstructured":"Ma G, Wang Y, Li Y et al (2015) MiR-206, a key modulator of skeletal muscle development and disease. Int J Biol Sci 11:345\u2013352. https:\/\/doi.org\/10.7150\/ijbs.10921","journal-title":"Int J Biol Sci"},{"key":"3821_CR263","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/emm.2004.1","volume":"36","author":"J-W Lee","year":"2004","unstructured":"Lee J-W, Bae S-H, Jeong J-W et al (2004) Hypoxia-inducible factor (HIF-1)alpha: its protein stability and biological functions. Exp Mol Med 36:1\u201312. https:\/\/doi.org\/10.1038\/emm.2004.1","journal-title":"Exp Mol Med"},{"key":"3821_CR264","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.mod.2012.09.004","volume":"130","author":"V Witzemann","year":"2013","unstructured":"Witzemann V, Chevessier F, Pacifici PG, Yampolsky P (2013) The neuromuscular junction: Selective remodeling of synaptic regulators at the nerve\/muscle interface. Mech Dev 130:402\u2013411. https:\/\/doi.org\/10.1016\/j.mod.2012.09.004","journal-title":"Mech Dev"},{"key":"3821_CR265","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.molmed.2006.01.002","volume":"12","author":"P Miura","year":"2006","unstructured":"Miura P, Jasmin BJ (2006) Utrophin upregulation for treating Duchenne or Becker muscular dystrophy: how close are we? Trends Mol Med 12:122\u2013129. https:\/\/doi.org\/10.1016\/j.molmed.2006.01.002","journal-title":"Trends Mol Med"},{"key":"3821_CR266","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-14463-4","volume-title":"Cell polarity 1 biological role and basic mechanisms","author":"K Ebnet","year":"2015","unstructured":"Ebnet K (2015) Cell polarity 1 biological role and basic mechanisms. Springer, Cham"},{"key":"3821_CR267","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1080\/15548627.2017.1378838","volume":"14","author":"L Yu","year":"2018","unstructured":"Yu L, Chen Y, Tooze SA (2018) Autophagy pathway: cellular and molecular mechanisms. Autophagy 14:207\u2013215. https:\/\/doi.org\/10.1080\/15548627.2017.1378838","journal-title":"Autophagy"},{"key":"3821_CR268","doi-asserted-by":"publisher","first-page":"2135","DOI":"10.1242\/jcs.127308","volume":"126","author":"K Hori","year":"2013","unstructured":"Hori K, Sen A, Artavanis-Tsakonas S (2013) Notch signaling at a glance. J Cell Sci 126:2135\u20132140. https:\/\/doi.org\/10.1242\/jcs.127308","journal-title":"J Cell Sci"},{"key":"3821_CR269","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/S0070-2153(10)92003-6","volume":"92","author":"B D'Souza","year":"2010","unstructured":"D\u2019Souza B, Meloty-Kapella L, Weinmaster G (2010) Canonical and non-canonical Notch ligands. Curr Top Dev Biol 92:73\u2013129. https:\/\/doi.org\/10.1016\/S0070-2153(10)92003-6","journal-title":"Curr Top Dev Biol"},{"key":"3821_CR270","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1002\/dvdy.24495","volume":"246","author":"B Pawlikowski","year":"2017","unstructured":"Pawlikowski B, Vogler TO, Gadek K, Olwin BB (2017) Regulation of skeletal muscle stem cells by fibroblast growth factors. Dev Dyn 246:359\u2013367. https:\/\/doi.org\/10.1002\/dvdy.24495","journal-title":"Dev Dyn"},{"key":"3821_CR271","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/s41556-020-0540-x","volume":"22","author":"S Zumerle","year":"2020","unstructured":"Zumerle S, Alimonti A (2020) In and out from senescence. Nat Cell Biol 22:753\u2013754. https:\/\/doi.org\/10.1038\/s41556-020-0540-x","journal-title":"Nat Cell Biol"},{"key":"3821_CR272","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.cell.2017.05.016","volume":"169","author":"R Nusse","year":"2017","unstructured":"Nusse R, Clevers H (2017) Wnt\/b-catenin signaling, disease, and emerging therapeutic modalities roel. Cell 169:985\u2013999. https:\/\/doi.org\/10.1016\/j.cell.2017.05.016","journal-title":"Cell"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-021-03821-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00018-021-03821-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-021-03821-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T19:53:31Z","timestamp":1698868411000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00018-021-03821-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,7]]},"references-count":272,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["3821"],"URL":"https:\/\/doi.org\/10.1007\/s00018-021-03821-x","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,7]]},"assertion":[{"value":"6 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}